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Abstract 
This thesis explores the development of microfluidic technology for generating and 
manipulating micro-sized vesicles with the incorporation of specific membrane 
proteins as artificial cellular systems to mimic natural existing cells.  
Synthetic biology (SynBio) is an emerging area of research concerned with the 
application of engineering methods to the creation of new biological processes and 
constructs. Understanding the working principle of living cellular system is one of 
significant issue for scientists working in this field. Cells are known as the basic unit 
of life: creating model synthetic analogues offers opportunities for us to deepen our 
insights of complex interaction and to understand features and functions of the living 
cells.  
Microfluidic technologies have provided the capabilities of compartmentalisation, 
monodispersity and high-throughput generation for engineering architectures 
resembling cell-like structures. In vitro transcription and translation (IVTT) enables 
the expression of specific proteins of interest within synthetic cells via encapsulation 
of cell-free protein expression solution has demonstrated artificial cells with the 
capability of containing the process of central dogma of molecular biology.  
The thesis investigates the building of synthetic cell-like constructs by microfluidics. 
The first area of investigation focusses on the fabrication of lipid/polymer vesicles 
transformed from ultra-thin shell double emulsions, which were prepared using 
microfluidics. To bring the biological function into both vesicle-based synthetic 
chassis, a fluorescent protein and a pore-forming membrane protein were in vitro 
expressed in the artificial cell chassis.  
The second area of study centres on the viscosity analysis of artificial cell membranes 
using a combination of molecular rotors and the fluorescence lifetime imaging 
microscopy. The membrane viscosity plays a crucial role in membrane proteins 
insertion that influences the cell function regulation through functional 
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biomembranes. The alteration of lifetime of the molecular rotors trapped in the 
artificial membranes reports the viscosity changes in the membrane environment 
induced by the dewetting process. Comparisons of viscosity values over time 
between lipid vesicle templated by thin-shell double emulsions with GUVs produced 
by an oil-free method (electroformation) offers the ability of measuring the amount 
of oil phase (organic solvent mixture) in artificial cell membranes.  
In the final chapter, the research detailed the construction of lipid bilayers with 
asymmetric arrangement used as more complex artificial cell models compared with 
most of synthetic cells with symmetric composition in their bilayers. A vesicle with 
hybrid asymmetric bilayer is also fabricated in same microfluidic fashion where 
phospholipid deposits on the inner-leaflet and block copolymer coats the outer 
monolayer. 
Taken together, the work presented in this thesis shows the potential to exploit the 
microfluidic construction of a functioning synthetic cell from individual molecular 
components, which could advance new application areas in biotechnology and 
health. Further developments in this research will aim to develop microfluidic 
technologies for: (i) physically investigating cell division process using lipid vesicles 
as cell models; and (ii) producing complex multicompartmental systems for the use 
of mimicking natural cells. The asymmetric bilayers will be studied for their 
influences on the integration of transmembrane proteins. 
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1.1 Synthetic Biology 
This thesis starts by introducing Synthetic Biology (SynBio), an exciting new 
discipline that combines science and technology and has arguably resulted in some 
of the most astonishing scientific breakthroughs, and led to the greatest increase of 
knowledge, in life sciences in the last few decades. Defined by a group of European 
experts, a consensus definition of SynBio is described as: ‘Synthetic Biology is 
essentially the engineering of biology that involves synthesis of complex systems 
which are either biologically based or inspired, to display functions that do not appear 
in nature. It is believed that this approach will enable the rational and systematical 
design of systems that might be applied into all scales of biological structure – from 
individual molecules to whole cells. (1)  
Despite being a relatively new research field, SynBio has undergone dramatic growth 
and has already led to unprecedented insights into the production of organisms for 
drugs (2) and biofuels (3), as well as the creation of a synthetic tissue using only 
genetic data. (4) In addition, a large number of reviews and books have been 
published discussing its worldwide economic impact. (5-8) In Figure 1.1, a timeline 
charts the technological and cultural lifetime of SynBio. All current, or intended, 
investigations focus on the design of artificial living systems, such as the construction 
of synthetic cells featured with natural cell functions that could be exploited to 
explore how a living system works and interacts. 
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Figure 1.1 A timeline shows the brief history of SynBio. Key to coloured boxes: 
scientific milestones (black), SynBio in metabolic engineering (green), 
therapeutic applications (blue). Image is modified from indicated reference. 
(9) 
 
1.1.1 Engineering Principles 
How is SynBio different from other subfields of biology? The crux lies in the 
application of engineering principles employed for the design of biological systems. 
(10) Standardisation of biological components is a foundation of SynBio and is also 
a significant research area that aims to develop standards for biological parts in order 
to enable them to be interchangeable. Modularisation places emphasises on 
separately designed component that can be either added together to yield complex 
functioning organisms or rationally removed to reduce the complexity to a simpler 
problem that can be independently understood and addressed by researchers. 
The aforementioned principles have already widely been applied to an important 
subfield of DNA design, namely the creation of BioBricks by Drew Endy, a pioneer 
in SynBio (11). BioBricks demonstrates the concept of designing genetic components 
that perform specific functions. In this thesis, these themes are translated to the 
engineering of both symmetric and asymmetric bilayer functional vesicles, built with 
naturally occurring molecules and synthetic compounds. 
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1.1.2 Top-Down and Bottom-up Approaches in SynBio 
The SynBio field is diverse, but it can be broadly divided into two separate and 
competing themes, Figure 1.2: the top-down approach, to design systems based on 
a natural organism that is used as a host for the engineering of new functions within 
it; the bottom-up methodology, seeking to assemble artificial biomimetic systems 
that are built on basic biological or synthetic compounds, creating synthetic cell 
mimicry. The molecular systems constructed using the bottom-up approach 
resemble biological cells and are referred to as artificial/synthetic cells or protocells. 
 
Figure 1.2 Two main approaches of synthetic biology, particularly in 
attempting to develop minimal living system. Top-down approach – minimal 
units derived from an existing organism. Bottom-up approach – refine the 
minimal units with synthetic or biological components. Image taken from the 
reference. (12) 
 
Well-established genetic engineering technologies give rise to broad applications of 
the top-down approach in the SynBio research. In terms of creating synthetic life, 
where many synthetic biologists attempt to move to, the top-down methodology can 
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be exploited to generate a minimal cell through rationally reducing a natural cell’s 
genomes until only essential genes remain. In this manner, exploring the specific 
functions of a living unit is achieved by decreasing the complexity of a modern living 
cell host. (13)  
Recent progress by Venter et al. demonstrated that synthesised genomes comprised 
hundreds of genes and can constitute a brand new synthetic species. (14, 15) 
However, this top-down strategy does not reveal how the gene products act together 
to create this brand new artificial life since the function of a third of its genes are 
unknown, leaving many open questions to scientists on how these viable cells 
essentially work. As our understanding of both the fundamental basic biological 
molecules and the application of advanced engineering technologies in SynBio 
rapidly grow, we are able to make further inroads into building cell-like structures by 
reconstructing a set of individual biological compounds. 
It is noteworthy that significant progress has been made in the bottom-up 
reconstitution of synthetic cellular machinery. (16-18) Beginning with simple 
molecules, scientists are not restricted to the natural principles of biological cells and 
brand new cell-mimetic systems can be designed, shedding light on specific biological 
process within cells and individual cell functions. Taking these approaches together, 
researchers are progressively better equipped to integrate basic individual biological 
systems into synthetic complex cell-like entities, bringing synthetic cells from the 
imagination to the reality. 
1.1.3 Ultimate Goal of  SynBio 
Cells are the smallest representation of a natural living organism. It is therefore one 
goal of SynBio to build a living cell out of non-living molecules. SynBio is emerging 
as a powerful technology, capable of engineering novel biological counterparts, and 
attempting to fulfil the audacious concept of the construction of a fully synthetic, 
activated cell. Design of synthetic cells is not only trying to understand better the 
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molecular underpinnings of cell behaviour to answer the question of how a cell 
works, but also developing diverse solutions to real-world problems. (19) 
1.2 Artificial Cell Models 
Artificial cell models can be defined as those cell-like counterparts bounded by 
bilayers constructed of either lipid molecules or block copolymers, which are referred 
to as the chassis. Compared with complex biological membranes integrated with 
membrane proteins, these model membranes are simply designed and produced only 
with building blocks, which retain key features of biomembranes, and allow 
investigations performed in relatively simple environments. As such, artificial cell 
models have proved to be a significant tool in the study of the mechanical properties 
of the membranes, as well as for studying transmembrane proteins. (20) In addition, 
efforts have been spent on the applications of these cell-mimetic systems, such as 
bio-sensing, (21) and DNA sequencing. (22) 
Generally, the model systems include bilayers in the form of solid substrate 
supported bilayers, Figure 1.3(A), droplet interface bilayers (DIBs), Figure 1.3(B), 
and vesicles, Figure 1.3(C). These three forms of model systems will be outlined as 
follows. 
 
Figure 1.3 Artificial cell model systems: (A) Schematic of lipid bilayers 
supported by a solid substrate; (B) Schematic of droplet interface bilayer 
(DIB) formed when droplets are brought into contact; (C) Schematic of lipid 
vesicular structures. 
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1.2.1 Supported Lipid Bilayers (SLBs) 
A supported bilayer is a biomimetic model membrane constituted of a planar 
structure of phospholipid molecules depositing on a solid support, which is typically 
formed by adsorption and fusion of vesicles, as shown in Figure 1.4. In such artificial 
membrane systems, the hydrophilic head groups of the bottom lipid monolayer are 
facing towards the substrate while hydrophobic tails of this lipid monolayer are in 
contact with the lipid tails of the upper monolayer. Because of the architecture of the 
SLB, the upper lipid monolayer is exposed to the aqueous medium, allowing SLBs 
to not only be used to characterise the chemical interactions between two free 
monolayers, but also to provide various tools for surface specific analyses. (20) 
 
Figure 1.4 Schematic illustration of common techniques for the formation of 
supported lipid bilayers. Vesicles in solution adsorb and spontaneously fuse 
to the solid surface to form a supported lipid bilayer. 
 
As an artificial cell membrane model, SLB has been popularly utilised to investigate 
the reconstitution of membrane proteins into artificial membranes. (23-25) However, 
one side of the polar head group freely floats in solution whereas the other side is 
tightly attached to the non-biological support, which may affect the mobility of 
membrane components that is the vital property of biomembranes in terms of the 
incorporation of transmembrane proteins. Additionally, within SLB model systems, 
random insertion orientations of integral membrane proteins have been frequently 
observed resulting in difficulty characterising the functions of targeted membrane 
proteins. 
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1.2.2 Droplet Interface Bilayers (DIBs) 
Droplet interface bilayers (DIBs) are artificial membrane models formed between 
two self-assembled lipid-monolayer stabilised water droplets brought into contact 
inside a droplet incubator of oil, Figure 1.3(B). The concept was first proposed by 
Tsofina et al. in 1966, (26) but it was not further studied until 2006 when Bayley and 
his team, as well as Takeuchi and his group, from Oxford and Tokyo respectively, 
started to investigate DIBs in great details pushing the research of artificial cell 
membranes a step forward. (27, 28) 
DIBs have provided facile and robust platforms as a consequence of the various 
advantages they confer, such as their high kinetic stability resulting in extended 
lifetime ranging from days to weeks, readily controlled electrical measurement by 
attaching hydrophilic electrodes and the ability to form asymmetric bilayer. (27, 29) 
There are two distinct methods of forming DIBs pioneered by Hagan et al. and 
Takeuchi et al., depending on how phospholipid molecules are assembled into the 
monolayers at the water-oil interfaces. The lipid-out technique uses lipids dissolved 
in the oil phase, Figure 1.5(A), whereas in the lipid-in approach, the lipid vesicles are 
encased in the inner aqueous phase, and burst at the water-oil interface forming a 
lipid monolayer, stabilising the droplets, Figure 1.5(B). In both approaches, the 
formation of symmetric DIBs, in terms of lipid composition where the two 
monolayers are identical, are readily controlled. However, the asymmetric bilayer, 
which is a more accurate membrane model of biomembranes, can be manufactured 
using the lipid-in method by using two specific lipid composition vesicles in 
separated water droplets, as shown in Figure 1.5(B). (30) 
 
 
9 
 
 
Figure 1.5 Schematic of formation of DIB: (A) Lipid-out DIB formation. 
Lipids are dissolved in the organic phase and self-assemble as a monolayer 
around each droplet. Two droplets are positioned in-pair forming a bilayer; 
(B) Lipid-in DIB formation. Two types of lipid vesicles with different 
compositions are present inside the water droplets. Vesicles fuse with the 
water-oil interface of the droplets and form monolayers. The droplets are then 
brought in contact to form an asymmetric bilayer. 
 
DIBs have been exploited for the incorporation of membrane proteins as well as 
electrophysical characterisation, including α-hemolysin (nano-size pore-forming 
protein), outer membrane protein G (OmpG), bacteriorhodopsin (BR, light-sensitive 
proton pump) and potassium channels of Kcv and KcsA. (27) Besides the 
functionalisation of DIBs with integral membrane proteins, by using the lipid-in 
approach, Bayley and his group have demonstrated that the effect of asymmetric 
DIBs on OmpG gating behaviour is based on the orientation of protein in 
asymmetric DIBs. (31) DIBs have also been conjugated with in vitro transcription and 
translation (IVTT) to cell-free express membrane protein inside droplets as an 
alternative method for electrical measurements of membrane proteins. Two reviews 
from Bayley et al. in University of Oxford have illuminated DIBs from concept  to 
recent applications. (27, 29) 
 
 
10 
 
1.2.3 Vesicles 
Vesicles are fluid-filled spherical architectures formed spontaneously by self-
assembly of phospholipids or of other molecules (e.g. fatty acids, block copolymers) 
as shown in Figure 1.6. In this thesis, efforts focus on the vesicles constructed with 
either phospholipids or block copolymers, which are liposomes and polymersomes, 
respectively. 
 
Figure 1.6 Schematic of vesicles: (A) A fatty acid vesicle. Fatty acid molecule 
is composed of a polar headgroup and a single-chained tail; (B) A lipid 
vesicle. Phospholipid molecule has a hydrophilic headgroup and hydrophobic 
double-chained tail group; (C) A polymeric vesicle (polymersome). Block 
copolymer is made of hydrophilic block and hydrophobic moiety. 
 
Vesicles have served as versatile biomimetic model membranes for studying 
membrane phase behaviour and membrane processes, including membrane fusion 
and molecular recognition. In early 1990s, Pier Luigi Luisi experimentally pioneered 
the construction of liposome-based cell models in the laboratory at the Swiss Federal 
Institute of Technology (Zurich). (32) Since then, vesicle-based models have been 
typically used as materials for cell-mimetic compartments that are also termed as 
artificial or synthetic cells, offering a promising tool for the insight into the 
understanding of the working of the living cell. (13, 16, 33) 
Traditionally, vesicles have been produced by a method called the gentle hydration, 
discovered by Bangham in 1964. (34) In this method, phospholipids are first 
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dissolved in an organic solvent, and then evaporated under vacuum until lipid films 
are formed on the container surface. After drying lipids, the films are hydrated at 
temperatures above the phase transition by adding an aqueous solution, forming 
liposomes finally. However, in this approach, vesicles cannot be produced with high 
encapsulation efficiency and it is difficult to control over the lamellarity property.  
A key step forward was the introduction of electro-formation approach pioneered 
by Angelova and Dimitrov in 1986. (35) The appearance of electroformation 
technique has dramatically increased the yield ratio and reduced time for preparation 
at the temperatures friendly with the biological components. (36) In electro-
formation production of vesicles, an alternating current (AC) is applied to the lipid 
films to enhance the hydration of the lipid films, resulting in tightly controlled sizes 
of vesicles.  
Progress in the application of vesicle-based artificial cell models has been achieved 
since vesicles can be manufactured in a more controlled manner. (37, 38) It is worth 
noting that restrictions exist to electro-formed vesicles prepared under physiological 
conditions or during the inclusion of charged phospholipid (such that lipid 
asymmetry found in native biomembrane cannot be mimicked using 
electroformation method). Recent developments in tool technologies have enabled 
monodisperse and asymmetric lipid vesicles to be engineered by using double 
emulsions as templates produced by microfluidics. (39, 40) In addition, the 
encapsulation efficiency of biomolecules into vesicles can be greatly enhanced using 
microfluidic technologies. The formation mechanism relies on the generation of 
water-in-oil-in-water double emulsions, where bilayer building blocks are dissolved 
in the oil phase. The residual volatile solvent in the oil phase is removed subsequently 
leading to the formation of the vesicle bilayers. Vesicles constructed using such 
double-emulsion templated approaches have been shown to be capable of 
performing as cell-like compartments. (38) 
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Figure 1.7 Schematic illustration of applications of vesicle-based artificial 
cells. Image taken from (18). 
 
Cell-like systems templated by vesicular architectures have been variously 
incorporated into either synthetic or biological modules, endowing the structures’ 
functionality, Figure 1.7. For example, high loading efficiency method enables 
vesicles containing cell-free protein synthesis machinery to investigate the proteins 
of interests; by reconstituting biological components into bilayers, essential cellular 
processes can be recreated, including the uptake of nutrients and the expulsion of 
waste, intracellular singling processes, commutations with natural cells and cell 
replication and division into daughter cells. (18, 41) 
1.3 Microfluidics 
Microfluidics is a science and technology of systems that deals with the control and 
manipulation of fluids of small volumes down to less than picolitres, that are 
geometrically constrained in chips at a microscale. (42, 43) The chips are often 
comprised of micro-sized channels and an individual micro-fabricated chip is integral 
to multiple laboratory functions enabling better analytical performance in high speed, 
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precise data collection, low sample consumption and minimal exposure to hazardous 
materials. (44) Such features have paved the way for the large numbers of 
applications of this technology span across science, for instance in biology, (45, 46) 
chemical, (47) and biomedical context. (48) Thus, this fascinating technology has 
shed light on multidisciplinary research from physics to synthetic biology. 
1.3.1 Droplet-based Microfluidics 
One subcategory of microfluidics is droplet-based microfluidics, which involves the 
generation and manipulation of discrete droplets with the use of immiscible phases 
inside microfluidic devices. (49, 50) Although the technology is still in its relative 
infancy, microfluidics was initially concerned with continuous flowing streams of 
miscible fluids. Droplet-based microfluidics has emerged from this, motivated by the 
construction of uniform-sized droplets with nanolitre volume as reactors for 
micrometre-scale total analysis systems (µTAS) research and fabrication of particles 
templated by droplets for materials research. (51) In the past decade, several groups 
have made an impressive success of droplet-based microfluidics in generating 
emulsion systems as novel micro-environments. (52, 53) Further, scientists from 
interdisciplinary background are taking the opportunity to engineer the cell-like 
architectures (synthetic cells) using a bottom-up approach by means of droplet-based 
microfluidics to study living cells. (41, 54) 
The fabrication of microfluidic devices is the first principle step in droplet 
microfluidics. To produce and control droplets and further achieve specific 
functions, the devices should be designed with a defined geometries and 
physicochemical properties, especially the surface properties. (55, 56) This requires 
demand-driven selection of materials determined by fabrication methods. At present, 
there are several types of manufacturing techniques for microfluidic chip fabrication; 
in droplet-based microfluidics, soft lithography and assembly of glass capillaries. (52, 
57) 
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Soft lithography was first proposed by Whitesides and his team members (Harvard 
University) and refers to a set of techniques for fabricating structures using an 
elastomeric material. Typically, the elastomer is poly(dimethylsiloxane), PDMS, 
which widely used for fabricating microfluidic chips in cellular applications because 
its nontoxicity and permeability to gas as well as being optically transparent for 
visualisation. The PDMS microfluidic chips are usually manufactured using following 
procedure. The liquid PDMS pre-polymer is cast into a silicon or photoresist mould 
fabricated by a photolithography process and treated by exposing to a vapour of 
fluorinated silane - which is used to prevent irreversible bonding to the PDMS. The 
pre-polymer is then degassed and then cured into solid PDMS before being peeled 
off the master. PDMS can be bonded irreversibly to substrate surfaces, such as glass 
after exposure to an oxygen plasma, Figure 1.8. Even with these advantages, PDMS 
is limited by the ease of surface property modification and the poor chemical 
compatibility with organic solvents. In addition, PDMS absorbs small molecules on 
its surface and is intolerant to high pressure, which results in damage of the 
microchannel geometry. 
 
Figure 1.8 Schematic illustration of soft lithography for fabricating PDMS 
microchannel. Image is modified from (58). 
 
Glass capillary microfluidic devices have superior optical and chemical properties 
and offer 3D symmetrical microchannels of which the surfaces can be 
straightforward functionalised. Weitz et al. from Harvard University have established 
an explicit droplet microfluidic system that aligns tapered round glass capillaries 
within a square capillary, which are then assembled on a glass slide as a whole, as 
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depicted in Figure 1.9. (52, 59, 60) The coaxial geometry is ensured by the size match 
between the outer diameter of the circular capillary and the inner diameter of the 
square capillary. In these capillary-based devices, the 3D configuration provided by 
the coaxial system allows the generation of droplets in either hydrophobic or 
hydrophilic systems, Figure 1.9(A). Moreover, by means of a complex design, 
capillary channels can align into sequential insertion or multichannel injection 
regimes for complex structure construction, Figure 1.9(B, C). 
 
Figure 1.9 Schematic demonstration of three types of microfluidic chips 
fabricated by coaxial assembly of size-matching cylindrical and square 
capillaries. Image taken from indicated references. (52, 59, 60) 
 
In terms of formation of droplets within microfluidic devices, depending on the 
specific design of the microfluidic channels and fluid configurations, droplet 
generation can be categorised into cross-flow, flow-focusing and co-flow techniques, 
Figure 1.10. In cross-flow, T-junction is the most common geometry used to 
generate droplets, in which the dispersed and continuous phases meet at an angle, 
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Figure 1.10(A). (61) In the flow-focusing geometry, the two immiscible phases are 
hydrodynamically focused and generate an elongation filament when passing through 
a contraction, then eventually forms into droplets, as illustrated in Figure 1.10(B). 
(62) Co-flow streams, Figure 1.10(C) are produced by using a set of coaxial 
microchannels where the dispersed and continuous fluids meet in parallel in the same 
direction. (63) This format of droplet microfluidics is typically achieved by a set of 
capillary-based devices, in which the size of droplets can readily control by altering 
the flow rate of continuous fluid with the viscous shear stress applied to the dispersed 
phase. 
 
Figure 1.10 Three geometries of microfluidic drop generators: (A) Schematic 
of T-junction droplet microfluidics; (B) Schematic of flow-focusing droplet 
microfluidics; (C) Scheme of coflow droplet microfluidics. 
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1.3.2 Droplet-based Microfluidics in Artificial Cells 
The droplet-based microfluidic technique enables the construction of microscale 
materials, such as water-in-oil-in-water double emulsion droplets, that mimic cell 
functions and features, or in other words artificial cells. The study of artificial cells is 
promoted by the abilities of compartmentalisation, high-throughput generation and 
monodispersity of droplet microfluidic technology, which have expanded the scope 
of engineering highly controlled cell-like systems as synthetic cells that are assembled 
by simple building blocks from the bottom-up. By taking the advantages of droplet 
microfluidics, not only can the size, shape and lamellar nature of artificial cells be 
readily customised according to experimental conditions, but the membrane 
composition with asymmetric lipid arrangement and functional complexity of cell-
mimics can be engineered. Although a large number of microfluidic approaches for 
the assembly of artificial cells have emerged, sophisticated artificial cells have not yet 
been assembled using the indispensable tool of droplet-based microfluidics. 
1.4 Thesis Aims 
The core objectives of this thesis are to construct and study synthetic cells by using 
microfluidic technologies in synthetic biology in order to synthesise membranes that 
at their interface mimic living cells. The first key research area investigated is the 
development of microfluidic techniques to design novel geometries and in so doing 
generate new cell-like systems. The second area of research concerns the 
characterisation of artificial membrane fluidity based on molecular rotors. The aims 
of the thesis are as follows. 
1. To design new microfluidic devices to prepare double emulsion droplets with 
ultra-thin membranes.  
2. To use thin-shelled double emulsion droplets as templates to form either 
lipid vesicles or polymeric vesicles.  
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3. To use these lipid vesicles and polymersomes as artificial cellular systems to 
perform in vitro transcription and translation. 
4. To develop a Fluorescence Lifetime Imaging Microscopy system to 
determine ability of molecular rotors to reveal on artificial cell membrane 
viscosity. 
5. To design and fabricate of a new microfluidic device to build artificial cell 
chassis with asymmetric arrangement in composition within the bilayers. 
1.5 Thesis Outline 
This thesis is organised in six Chapters, which are structured as follows. 
Chapter 2 gives the theory background of the fluorescence as well as the advanced 
fluorescence imaging techniques: Confocal Laser Scanning Microscopy and FLIM. 
The fundamental theory of the fluid mechanics at microscale for microdroplet 
formation. 
Chapter 3 details work relating to the construction of lipid vesicles and polymeric 
vesicles based on thin-shelled double emulsion droplets that are generated by 
microfluidic technique and introduction biological functionalities (in vitro 
transcription and translation) into these cell-like compartments, transforming them 
into artificial cells. 
Chapter 4 describes the utilisation of a FLIM system to perform measurements on 
the BODIPY based molecular rotor in artificial cell membrane synthesised in the 
microfluidic device. 
Chapter 5 outlines the development of the microfluidic strategy to generate vesicle-
based cell-mimic systems with asymmetric bilayers at high-throughput. 
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Chapter 6 summarises the presented work and indicates some of the avenues that 
future works could focus on. 
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Chapter 2 Instrumentation and Theory of  
Techniques 
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2.1 Fluorescence Microscopy of  Biomembranes 
Biological research has benefited from the advance of key methodologies. In fact, it 
was the development of microscopy by Robert Hooke in 1665 that shaped and 
deepened our understanding of cells as the basic units of living systems. (64) 
Biological membranes play a significant role in cell structure, shape, and functions. 
At its most basic level, the biomembrane encloses the cell and isolates its interior 
from the outer environment. Nowadays, it is well recognised that biological 
membranes are highly heterogeneous systems in which embedded molecules show 
complex diffusion behaviours and change of spatiotemporal organisation in response 
to signals, rather than the simplistic picture of “fluid mosaic model”. Fluorescence 
spectroscopy and microscopic techniques are central to the elucidation of biological 
membranes’ properties, which are attributable to the sensitivity to access the single 
molecule level, and the large spatial resolution. This powerful widely used method 
has propelled modern biomembrane studies to fully new levels. (65-68) 
2.1.1 Fluorescence 
Since Sir John Herschel made the first observation of fluorescence from his quinine 
sulfate in tonic water as it was illuminated by sunlight in 1845, (69) the phenomenon 
known as fluorescence has been a long-standing interest in the use of studying the 
structure and functioning of biomembranes. (65, 70, 71) Fluorescence is a process in 
which light is emitted from molecules after photons of light are absorbed. The 
molecules that exhibit fluorescence are called fluorophores or fluorochromes. Upon 
the absorption of a photon of light, a range of photo-physical processes take place 
within fluorophores, which are demonstrated in the Jablonski energy diagram in 
Figure 2.1. 
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Figure 2.1 Jablonski energy diagram. Graphic demonstration of the paths that 
electrons, after excitation at the light of the corresponding wavelength, go 
back to their previous ground state (S0). Absorption of light occurs in 10
-15 
seconds. In the case of fluorescent light emission, the process is rapid and it 
takes 10-9 seconds whereas the phosphorescent emission is slower taking 10-3 
- 10-2 seconds. Image taken from (72). 
 
When a photon is absorbed, orbital electrons in fluorophores are elevated to higher 
energy levels. In Figure 2.1, the thick black lines illustrate the electronic states and 
thinner lines represent the vibrational states. If the transition is associated with 
absorption or emission of a photon, the transitions between the states are illustrated 
as straight arrows. Transitions that results from a molecular internal conversion or 
non-radiative relaxation process are shown as wavy arrows. (72) Excitation of a 
fluorescent molecule by an incoming photon occurs on the order of 10-15 seconds, 
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whereas vibrational relaxation of excited state electrons to the lowest energy level, S1, 
is much slower and can be assessed in 10-12 seconds. The final process, emission of 
a longer wavelength light and return of the molecule to the ground state, S0, happens 
in the relatively long time frame of 10-9 seconds. 
One pathway for molecules to react as a result of the energy received from photons 
is to emit a photon, termed as fluorescence. Electrons decaying directly from S1 to 
S0 emit energy, however in some molecules the spins of the excited electrons can be 
switched to a triplet state through a process called intersystem crossing, which is an 
another path a molecule may take in the dissipation of energy. Following this path, 
the electron changes spin multiplicity from an excited singlet to an excited triplet 
state. When occupying an excited singlet state, an electron’s spin is paired with the 
ground state electrons. However, when occupying an excited triplet state, an 
electron’s spin is not paired to the ground state. Electrons in an excited triplet state 
can therefore persist for longer than if they were in an excited singlet state. Inevitable 
decay to the ground state emits a photon, termed phosphorescence, on a time frame 
several orders of magnitude slower than fluorescence. Phosphorescent emission 
usually occurs over a time frame of 10-3 – 102 seconds compared to the 10-9 second 
time frame for fluorescent emission, known as the fluorescence time. Excitation to 
an excited triplet state is far less probable than to an exited singlet state as it involves 
a forbidden electron spin transition. (72, 73) 
The resultant energy associated with fluorescence emission transition as shown in 
Figure 2.1 is typically lower than that of incident excitation, the resulting emitted 
photons have less energy and are shifted to longer wavelength. This shift in 
wavelength is generally known as the Stokes Shift that was first observed and 
reported by Sir G. G. Stokes in 1852, (74) and is represented in Figure 2.2. 
This shift in emitted wavelength is the basis for any technique deriving information 
as a result of fluorescence. The ability to selectively detect light based on its 
wavelength enables systems to separate the emitted fluorescence photons from the 
incident excitation photons. 
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Figure 2.2 Schematic illustration of stokes shift spectra. Shift in excitation and 
emission spectra due to loss of excitation energy by electron relaxation and 
intramolecular vibration taking place between the different excited states. 
 
Many factors affect the fluorophore performance as related to fluorescence. 
Amongst the most important are: the fluorescence quantum yield, 𝜑 , the 
fluorescence lifetime, 𝜏𝐿 and the extinction coefficient, 𝜀. (70) 
The fluorescence quantum yield of a fluorophore is the ratio of fluorescence photons 
emitted to photons absorbed. Quantum yield values below 1 occurs and results in 
the loss of energy through non-radiative pathways, such as heat or a photochemical 
reaction, rather than the radiative pathway of fluorescence. The quantum yield, 𝜑, is 
dependent on the constants of radiative rate, 𝑘𝑟, and non-radiative rate, 𝑘𝑛𝑟, shown 
in Equation (2.1). 
 𝜑 =  
𝑘𝑟
𝑘𝑟 +  𝑘𝑛𝑟
 (2.1) 
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The fluorescence lifetime ( 𝜏𝐿 ) is theoretically defined as the average time the 
molecule spends in the excited state prior to return to the ground state. Generally, 
fluorescence lifetimes are of the order of a few nanoseconds and are reciprocally 
proportional to the sum of the radiative (𝑘𝑟) and non-radiative (𝑘𝑛𝑟) rate constants: 
 𝜏𝐿 =  
1
𝑘𝑟 + 𝑘𝑛𝑟
 (2.2) 
The radiative decay rate is an intrinsic property of the fluorescent molecule; however, 
the non-radiative decay rate can be affected by the environment in which the 
fluorophore resides. Various processes are known to alter this pathway such as: 
internal quenching, dynamic quenching, and energy transfer. (75) 
The third key parameter relating to a molecule’s fluorescence is the extinction 
coefficient. This is a measure of the efficiency of a fluorophore to absorb a photon 
of light at a certain wavelength and is denoted as 𝜀, in units of M-1cm-1. The value of 
𝜀 is specified for the absorption maximum wavelength and typical values are found 
between 25,000 to 200,000 M-1cm-1. Larger extinction coefficients indicate that the 
absorption of a photon in a given wavelength region is more likely. 
2.1.2 Fluorescence Microscopy 
The technique of fluorescence microscopy has become an essential tool in biology 
and biomedical science due to its unique attributes that are not readily available in 
other contrast modes within conventional optical microscopy. Using fluorescence 
instead of, or in addition to, reflection and absorption facilitates the study of labelled 
biological molecules in samples with spatial and temporal resolution at the single cell 
level. The microscopy techniques exist in numerous forms and configurations with 
advantages depending on the desired applications. 
Most fluorescence microscopes commonly used in biology are based upon the 
epifluorescence configuration, where “epi” is from the Greek to mean “same”. In 
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this arrangement, both the illuminated and emitted light travels through the same 
objective lens. Key to the function is a dichroic mirror (No. 3 below). The 
fluorescence passes emitted by the specimen is focused on the detector or a camera 
by an objective lens that is also used for the excitation light being guided into. (66) 
The basic configuration can be seen in Figure 2.3. 
 
Figure 2.3 Epifluorescence microscope. 1 – Detector which is typically a CCD. 
2 – Emission filter passing fluorescence light only. 3 – Dichroic mirror 
separating excitation light from fluorescent signal. 4 – Excitation filter. 5 – 
Light source typically a mercury arc light source. 6 – Objective lens. 7 – 
Sample. 
 
Typically, the light from the source, which is placed vertically to the optical path, 
passes through an excitation filter and hits a special mirror called a chromatic beam 
splitter, also known as a dichroic mirror. The dichroic mirror is positioned above the 
objective lens and oriented at 45° to the light beam. The dichroic mirror has a special 
interference coating, which reflects light with wavelength shorter than a certain 
wavelength and transmits light of longer wavelength. Thus the higher energy 
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excitation light is reflected and directed through the objective lens towards the 
specimen. The emission light passes back through the objective lens to the dichroic 
mirror. The emitted light has a longer wavelength than the excitation light and is 
instead transmitted. Incident emission light with shorter wavelength that is reflected 
by the sample is not able to pass through the dichroic mirror and will be blocked. If 
the excitation light is able to pass through the dichroic mirror it will be further filtered 
by a barrier or emission filter before reaching the eyepiece or camera. (71, 76) 
Although epifluorescence microscopy has several advantages, such as low cost of set 
up with fast temporal resolution, providing good XY dimension resolution, all of the 
emitted fluorescence light is integrated through the specimen in the Z dimension 
collected by the detectors. Therefore, it is difficult to tell where the fluorescence from 
a point in the sample originated in the Z dimension. (77) 
2.1.3 Confocal Laser Scanning Microscopy (CLSM) 
Confocal microscopy is a technique first developed in 1957 by Marvin Minsky. It is 
capable of imaging optical sections of biological samples and overcomes the 
limitation of conventional fluorescence microscopy. (78) This is achieved by means 
of using a point illumination source and a pinhole in an optically conjugate plane in 
front of the detector to filter out-of-focus signals. As a result, only light emitted by 
fluorescence close to the focal plane can pass the pinhole, thus resolving an image of 
the specimen at a particular depth as depicted in Figure 2.4. 
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Figure 2.4 Confocal laser scanning microscopy. 1 – Detector. 2 – Confocal 
aperture. 3 – Dichroic mirror. 4 – Illuminating aperture. 5 – Point source. 6 – 
Objective lens. 7 – Sample; Principle of confocal detection optics. 
Fluorescence light is collected by the objective lens and directed to the 
detector via a small pinhole. The pinhole blocks light that does not originate 
from the focal plane creating a thin optical section. The red and green lines 
represent fluorescence originating from out of focus regions, whereas black 
line represents fluorescence light originating from focal plane in the sample. 
 
A laser is used to provide coherent light that interacts with two mirrors that directs 
the light to the sample and scan the laser across the sample. A microscope objective 
lens is adopted to focus the laser beam onto the specimen, where it excites 
fluorescence. As the laser is reflected by the dichroic mirror and scanned across the 
specimen in a defined focal plane, secondary fluorescence emitted from points on 
the specimen (in the same focal plane) pass back through the dichroic mirror and are 
focused as a confocal point at the detector pinhole aperture. (79) However, as a 
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significant amount of the fluorescence light from the specimen is blocked at the 
pinhole in front of the detector, this increased resolution is at the cost of decreased 
signal intensity, thus long exposure time are often required while operating a confocal 
microscope. To aid sensitivity, the fluorescence light is typically detected by a 
sensitive detector, usually a photomultiplier tube (PMT) that transforms the light 
signal into an electrical one that is recorded by a computer. (77) Due to the 
advantages of the confocal microscopy imaging technique, biomembrane research 
has been boosted in recent decades, such as in the study of the phase separation of 
lipid mixtures in artificial membranes, (80) asymmetry feature of biomembranes, (81, 
82). 
2.1.4 Fluorescence Lifetime Imaging Microscopy (FLIM) 
Fluorescence lifetime imaging microscopy (FLIM) has emerged as a reliable imaging 
technique driven by measurement of the fluorescence lifetime of molecules. The first 
instrument integrating time resolved fluorescence spectroscopy with microscopy 
dates back to 1959, (83) but only single point measurements could be done. In 1989 
an instrument enabling spatially resolved lifetime measurements was introduced. (84) 
Since then, a variety of fluorescence lifetime microscopy tools, mainly utilised for 
biomedical applications, have been developed independently by several groups. As 
detailed above, optical imaging techniques especially fluorescence imaging tools are 
widespread techniques in the biological and biomedical application. These standard 
fluorescence microscopies rely on generation of contrast in images through 
manipulation of the fluorescence intensity, which can be acquired from absorption, 
polarisation and fluorescence parameters in a fluorescence microscope. (70) 
However, fluorescence intensity is intrinsically dependent upon various 
environmental factors, such as the concentration of the fluorophore, quenching by 
other molecules, aggregation and energy transfer, and can therefore provide incorrect 
quantitative results and be open to misinterpretation. 
FLIM provides contrast according to the fluorescence lifetime of a fluorescent 
molecule. The fluorescence lifetime depends upon the intrinsic characteristics of the 
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fluorophore itself and is mostly independent of its concentration. The lifetime of a 
fluorescent molecule is sensitive to its local environment in general, the local 
viscosity, pH, temperature as well as interactions with other molecules. (75) What 
makes FLIM such an attractive technique for imaging intricate systems where control 
over probe distribution is difficult is the fact that the property of the lifetime is 
unaffected by the probe concentration and photobleaching. Theoretically, the 
fluorescence lifetime is defined as the average time a fluorophore spends in the 
excited state before emitting a photon and returning to the ground state and this is 
characterised by the decay of fluorescence intensity upon excitation. This decay of 
the excited state of a fluorescent molecule to the ground state is defined as: 
 𝐼(𝑡) =  𝐼0𝑒
(
−𝑡
𝜏 ) (2.3) 
where 𝐼0 represents the intensity at time zero, just after excitation and 𝜏 indicates the 
fluorescence lifetime. 
FLIM techniques can be classified according to the two major methods of data 
acquisition: time-domain FLIM and frequency-domain FLIM. In this chapter, the 
fundamental theory of time-domain FLIM will be discussed as time-domain FLIM 
as this is the technique used in this thesis. In the time-domain method, the 
fluorescent probe is excited by a short laser pulse that is usually applied repetitively 
in the MHz ranges. The time-dependent emission intensity is measured against time, 
and the decay time is determined from the slope of the decay curve, Figure 2.5. There 
are two fluorescence detection methods are available for time-domain lifetime 
measurements, of which, time-correlated single photon counting (TCSPC) enables 
simple data collection and enhanced quantitative photon counting. (85) 
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Figure 2.5 Principle of time-domain lifetime measurement. Fluorophores are 
excited using a short pulse of laser, after which the emitted fluorescence is 
measured time-resolved. Image taken from indicated reference. (86) 
 
2.1.4.1 The Principle of TCSPC  
TCSPC based FLIM systems are sensitive techniques that provide high precision 
fluorescence decay data from even just a few hundred photons. (87) TCSPC is based 
on the detection of single photons of a periodic light signal, the measurement of the 
detection time of an individual emitted photon, and the reconstruction of the 
waveform from the individual time measurements. (88) Excitation is enabled by 
using a short flash of light through commercially available, affordable laser diode 
sources presently offering repetition rates up to 100 MHz with extremely short pulse 
widths. The resultant fluorescence is most frequently detected by a highly sensitive 
photomultiplier tube (PMT) that is designed for low level detection of light. Single 
photons can also be detected by semiconductor diodes which can operate in the 
triggered avalanche mode, single-photon avalanche diode (SPAD). In Figure 2.6, the 
detection of photon events relative to the high repetition rate optical signal is 
demonstrated. 
Figure 2.6 (A) shows the stream of excitation originated from a high repetition laser 
diode at 40 MHz in this case. The photon detection rate shown in trace, Figure 
2.6(C), is about 107 s-1, which is on the order of the maximum possible detection rate 
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of most photon counting detectors. It can be seen in Figure 2.6 that, as detection is 
rather unlikely, the recorded photon stream is a random sequence of uncorrelated 
events, in contrast to the expected continuous signal of individual decays from each 
excitation pulse. Thus, the fluorescence decay waveform has to be constructed from 
the photon density as a function of the time after the excitation pulse. 
 
Figure 2.6 Schematic illustration of detection of individual photon events: (A) 
Fluorescence of a sample is excited by a laser of high repetition rate (40 MHz); 
(B) The expected fluorescence decay waveform; (C) The detection of single 
photon events representative of a realistic system consists of a few pulses 
randomly spread over the time axis. 
 
This concept shown in Figure 2.7 is the classic principle of TCSPC. (89, 90) The 
trace, Figure 2.7(A), illustrates the expected decay waveform within the signal period 
defined by the high repetition rate of laser. Trace (B) demonstrates a representative 
distribution of detected photon events within each sample period, continuing for the 
duration of the acquisition. Histogram (C) reveals the typical result of TCSPC that is 
the histogram with an exponential drop of counts at increasing times reflecting the 
fluorescence decay. 
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Figure 2.7 Principle of TCSPC: (A) Original decay curve representative of the 
distribution of photon probability; (B) Individual periods defined by the pulse 
of a repeating laser signal; (C) The build-up of all detected photon events for 
a number of time bins after numerous repetitions of the laser pulsed detection 
period. 
 
2.1.4.2 Exponential Curve Fitting 
In all time-domain based FLIM measurements, once the data has been acquired the 
information is interpreted and analysed by fitting to exponential decay functions. A 
single exponential of fluorescence decay is observed from a single molecule, or a 
homogeneous sample in which all fluorescent molecules within are observed under 
the same environment. Decay functions of complex samples of different molecules 
or of molecules within spatially resolved location are sums of exponential functions 
with different decay times. The model functions used in fluorescence lifetime analysis 
for a single, double and triple exponential systems are shown below. 
Single exponential model: 
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 𝑓(𝑡) =  𝑒−𝑡 𝜏⁄  (2.4) 
Double exponential model: 
 𝑓(𝑡) =  𝑎1𝑒
−𝑡 𝜏1⁄ + 𝑎2𝑒
−𝑡 𝜏2⁄  (2.5) 
Triple exponential model: 
 𝑓(𝑡) =  𝑎1𝑒
−𝑡 𝜏1⁄ + 𝑎2𝑒
−𝑡 𝜏2⁄ + 𝑎3𝑒
−𝑡 𝜏3⁄  (2.6) 
The models are characterised by the measured lifetimes of the exponential 
components, 𝜏𝑖, and the amplitudes of the exponential components, 𝑎𝑖. In principle, 
models with any number of exponential components can be defined, thus most of 
modern FLIM image analysis software packages are able to fit up to 3 or 4 
exponential decay components. However, higher-order models with more than 4 
components require significant signal resolution in order to accurately fit each 
component curve uniquely. In practice, the accuracy of the interpretation of such 
complex data can be difficult to obtain. Therefore, FLIM analysis does not use model 
functions with more than three components. (87) 
2.1.4.3 The Instrument Response Function (IRF) 
In a real FLIM system the fluorescent molecules are excited by laser pulses of non-
zero width, and detected by a detector that has a temporal response of non-zero 
width. These factors must be considered when operating FLIM systems and 
analysing fluorescence decay functions. To compensate for these elements in 
practical measurements, the instrument response function (IRF) which describes the 
spread of photon arrival times due to purely instrumental effects, including the 
detector, laser profiles and any optical reflections within the system, must be known. 
Thus, the IRF is central to the correct analysis of FLIM measurements as it takes 
into account anything that will alter the shape of the measured fluorescence decay 
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function. The convolution of the IRF with the decay function results in the recorded 
decay function. Mathematically, this can be expressed as: 
 𝑓𝑚(𝑡) =  ∫ 𝑓(𝜏)𝐼𝑅𝐹(𝑡 − 𝜏)𝑑𝜏
𝑡
𝜏=0
 (2.7) 
where 𝑓𝑚(𝑡) is the measured fluorescence function and 𝑓(𝜏) represents the true 
fluorescence decay function. In the above convolution integral, 𝑓𝑚(𝑡)  is not 
accurately known as a result of systematic noise in photon detection. The standard 
approach to obtain final fitted function is to convolute both the IRF and the defined 
model exponential fluorescence decay function as shown in Equations (2.4 – 2.6). 
(89) By using DCS – 120 Confocal Scanning FLIM System the IRF can be measured 
at a width of only a few tens of picoseconds with detection of a pulse directly from 
the illuminating source. The FLIM image analysis software packages have the ability 
to use a measured IRF that can be deconvoluted from the recorded fluorescence 
decay function delivering correct lifetime data. 
2.2 Theoretical Background 
2.2.1 Physical Background of  Microfluidics 
The term microfluidics refer to the science and technology that deals with the flow 
of liquids inside micrometre-size channels, and is utilised as systems to manipulate 
fluids of small amounts, generally on the nanolitre scale and below. (43) The 
dimensions of microfluidic systems exploit the counter intuitive characteristics of 
fluids at these scales. The fluid motion in a micrometre-size channel can be 
represented by laminar flow. (91) 
By controlling and understanding fluid dynamics and chemical composition, it has 
been demonstrated that microfluidic devices are able to fabricate emulsions, which 
are structures of two immiscible fluids mixed together, where one fluid is dispersed 
in the form of small droplets inside the other fluid. To understand the behaviours of 
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fluids at the micro scale, and the formation of microdroplets within devices, it is 
necessary to be familiar with the underlying physics of fluid mechanics. 
The first fundamental equation of fluid mechanics for the most general case of 
motion of a material is expressed by the continuity equation, which expresses the 
conservation of mass, as shown: 
 
𝜕𝜌
𝜕𝑡
+ ∇ ∙ (𝜌𝐮) =  0 (2.8) 
In many cases, especially in microfluidics, where the flow velocities are much smaller 
than the sound velocity in the liquid. Thus, the fluid can be treated as being 
incompressible. Considering a constant density in space and time, and the continuity 
equation (2.8) becomes 
 ∇ ∙ 𝐮 =  0 (2.9) 
For a Newtonian fluid, the velocity field obeys the Navier-Stokes equation, Equation 
(2.10), which essentially represent the continuum version of Newton’s 2nd Law (𝐅 =
𝑚𝐚), on a per unit volume basis: 
 𝜌 (
𝜕𝐮
𝜕𝑡
+ 𝐮 ∙ ∇𝐮) =  − ∇𝑝 +  𝜂∇2𝐮 + 𝐟 (2.10) 
where 𝜌 is the fluid density (Kg m-3), 𝐮 is the flow velocity (m s-1), 𝑝 is the pressure 
(N m-2), 𝜂 is the fluid viscosity (Pa s) and 𝐟 represents the sum of the body forces 
(N). As previously stated, for an incompressible fluid, where the density is considered 
uniform in every part of the fluid so that in microfluidic devices inertial forces are 
small compared to viscous forces and thus the nonlinear term can be neglected, the 
equation can be simplified to the Stokes equation, Equation (2.11): 
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𝜕𝜌
𝜕𝑡
+  ∇ ∙ (𝜌𝐮) =  0 (2.11) 
In fluid dynamics, the ratio of inertial and viscous forces is represented with the 
dimensionless Reynolds number (Re), Equation (2.12), which is the one most often 
mentioned in connection with microfluidics defined as: 
 Re ≡  
𝜌𝑈0𝐿0
𝜂
 (2.12) 
where 𝜌 is the density, 𝑈0 is a the fluid velocity and 𝐿0 is a characteristic length. For 
common microfluidic devices, the Reynolds number can be estimated. Considering 
water as the working fluid, typical velocities in the range between 1 µm s-1 – 1 cm s-
1, and channel radii of 1 – 100 µm, the Reynolds numbers range between 10-6 and 10. 
With these low values of Re, microfluidic systems are able to exploit linear regular 
deterministic flows. 
In the form of laminar flow two streams flowing side by side will flow parallel to one 
another, and mixing between them will occur via diffusion. Figure 2.8 depicts this 
regime. 
 
Figure 2.8 Schematic of laminar flow: (A) Schematic depiction of laminar 
flow; (B) In laminar flow, two streams flowing parallel to each other with only 
mix through diffusion (black dotted arrows). 
 
Typically, when Re < 2300 viscous forces dominate, leading to laminar flow, which 
occurs in most situations of microfluidic experiment. The presence of laminar flow 
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in microfluidic devices has been used for applications such as reagent separation, 
rapid mixing, and for the creation of concentration gradients. (92) 
In the laminar fluid flows that naturally arise in the low Reynolds number world of 
microfluidics, however, mixing occurs only by diffusion and can therefore result in 
long mixing times. The dimensionless Peclet number (Pe) expresses the relative 
importance of convection to diffusion, Equation (2.13). 
 Pe ≡  
𝑈0𝑤
𝐷
 (2.13) 
where 𝐷 is the diffusivity of a substance (m2 s-1), and 𝑤 is the width of the channel. 
The interplay of these two effects can be demonstrated in a microfluidic device, 
called a T-sensor, which is a very useful tool for applications. (93) Furthermore, the 
relationship between diffusion and convection can also be exploited for sorting and 
filtering. (94, 95) Thus, low Reynolds and Peclet numbers characterise a laminar flow 
regime where mixing of two joining fluids is dominated by diffusion. 
2.2.2 Physical Background of  Microdroplet Formation in 
Microfluidic Devices 
Emulsions, the products fabricated by microfluidics concerned in this thesis, are one 
form of micro-sized droplets. (96-98) An emulsion is a mixture of two immiscible 
liquids, where one liquid is dispersed as droplets in another, and has been extensively 
studied ever since Lord Rayleigh started research on the breakup of fluid jets 
projected on another fluid in 1879. (99) Early investigations on emulsions all used 
bulk mixtures of immiscible phases to produce quantities of droplets having a wide 
range of sizes by shear or impact stresses generated by manual or mechanical 
agitation. (100, 101) 
As previously described in Chapter 1, with the advent of microfluidic techniques, it 
is possible to produce highly monodispersed microdroplets in high-throughput with 
size ranging from a few micrometres to hundreds of micrometres, manipulate 
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individual droplets and precisely control their properties. (101) Generally, the 
monodispersity of the prepared emulsion is characterised by the coefficient of 
variation index (𝐶𝑉), shown in Equation (2.14), defined as the standard deviation of 
the droplet diameters in the emulsion, expressed as a percentage. (102) 
 𝐶𝑉 =  
1
𝑑
[∑(𝑑𝑖 − 𝑑)
2
𝑛
𝑖=1
(𝑛 − 1)⁄ ]
1
2
×100% (2.14) 
where 𝑑𝑖 is the diameter of the emulsion, 𝑑 is the arithmetic average diameter, and 
𝑛 is the number of emulsions measured. 
Various methods for droplet formation have been exploited in recent years. All of 
them have in common a carrier phase, known as a continuous phase, and a dispersed 
phase which represents the actual fluid of the droplet. The most common strategy 
of droplet production, which is flow rate-driven flow accomplished using syringe 
pump, involves the use of immiscible fluids actuated by constant volumetric flow 
rate (l s-1) of dispersed and continuous phase liquid (QD and QC). 
Between immiscible fluids, a surface tension 𝛾  affects the dynamics of the free 
surface. Todd Thorsen first demonstrated that controlled droplet emulsions in 
immiscible phases could be created by a microfluidic device, in which viscous shear 
forces tend to extend and drag the interface, whereas surface tension tends to reduce 
the interfacial area, shown in Figure 2.9. (103) These stresses destabilise the interface 
between two immiscible fluids and lead to formation of droplets. (104) 
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Figure 2.9 Uniform microdroplet generation in a simple microfluidic device. 
Image taken from (103). 
 
In the understanding of droplet (emulsion) generation within a microfluidic device 
that comprises two immiscible fluids, the Capillary number (Ca), Equation (2.15), is 
a dimensionless parameter found whenever interfacial stresses compete with viscous 
forces. Moreover, the Capillary number is the most important of several key 
dimensionless parameters that can be used to analyse the relative importance of each 
of the key forces for droplet breakup. (105) 
 Ca ≡  
𝑈0𝜂
𝛾
 (2.15) 
in which 𝑈0 is the main velocity of the continuous phase in the microfluidic channel, 
𝜂 the viscosity of the outer phase and 𝛾 the surface tension between the two fluids. 
In microfluidic droplet formation, Capillary numbers typically range from 10-3 to 101 
for flow rates accessible using syringe pumps. Commonly, inertia also plays a role in 
the droplet production, even if it is the least significant of the three key entities in 
microfluidics (viscous stress, capillary pressure and inertia). (50, 53) 
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Different regimes of droplet breakup can be achieved by adjusting the value of the 
Capillary number, resulting in differing droplet sizes, degrees of monodispersity as 
well as mechanism of droplet formation, as displayed in Figure 2.10. 
 
Figure 2.10 Regimes of droplet formation in a microfluidic device, in order of 
appearance as capillary number increases. Image taken from (106). 
 
When a microfluidic device is operated at low Capillary numbers, droplet generation 
occurs in the geometry controlled regime, (107) where the minimum droplet size is 
restricted to the same order of magnitude as the orifice. During droplet formation, 
the dispersed fluid interface is drawn into the orifice, which forces the continuous 
phase liquid to flow in a narrow region around the fluid-fluid interface. To maintain 
the flow rate employed by syringe pumps, the shear force from the continuous fluid 
is higher in this narrow region, resulting in a pinching of the interface that forms 
discrete droplets of the dispersed phase. The finger of dispersed phase fluid then 
retracts back to the position of the orifice and this process repeats itself, exemplified 
in Figure 2.10(A). With further increasing of the Capillary number, the formation of 
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droplet occurs into dripping mode, Figure 2.10(B), where the droplets turn out to be 
smaller than the size of orifice. In addition, the finger of the dispersed phase becomes 
longer and narrower than the one in the geometry controlled regime. Continuing to 
increase the Capillary number gives way to the jetting regime shown in Figure 
2.10(C), in which dispersed fluid liquid finger extends beyond the orifice and mimics 
a jet. (52) Typically, the jetting regime is not appropriate in microfluidic experiments 
as the fluid jet breaks into discrete droplets that are less monodisperse. 
2.2.3 Wetting and Dewetting 
Wetting is the ability of a liquid to maintain contact with a surface, whereas dewetting 
indicates the rupture of a thin liquid film on a substrate forming a droplet. In the 
fabrication of microfluidic devices, it is important to select materials with the right 
wetting property since wettability of microchannel surfaces has a strong influence on 
the formation of droplets and determines which liquid phase is dispersed. (105) For 
instance, in the generation of an oil droplet in a continuous aqueous phase, in order 
to produce droplets consistently, it is significant that the continuous water fluid 
preferentially wets the channel surface within the microfluidic device. Additionally, 
in Figure 2.11, a convex meniscus of dispersed oil phase forms in the microchannel 
that is helpful for the droplet formation. 
 
Figure 2.11 Schematic illustration of oil behaviour in hydrophilic and 
hydrophobic channels: (A) the cohesion forces of molecules of the fluid are 
higher than adhesion forces to the surface; (B) is the inverse. 
 
 
 
43 
 
Direct measurement of wettability within microchannels is difficult, however it can 
be indirectly obtained through an assessment of the contact angle 𝜃 formed at the 
liquid-substrate interface, Figure 2.12, where the substrate surface is modified by 
means of the same method as used for the microchannel. A contact angle of less than 
90° (low contact angle) usually indicates a favourable high degree of wetting with 
fluid spreading over a large area of the surface, displayed in Figure 2.12(A). Contact 
angles greater than 90° (high contact angle) generally express unfavourably low 
wetting, so the fluid on the surface minimises contact with the substrate surface and 
forms a compact liquid droplet. Water solution on the substrate surface, for example, 
which is with a low contact angle is termed hydrophilic, whereas that with high 
contact angle is referred to as hydrophobic surface. 
 
Figure 2.12 Contact angle 𝜽  of a water droplet on hydrophilic and 
hydrophobic surfaces and vectorial representation of surface tension between 
solid and liquid 𝜸𝐒𝐋, solid and gas 𝜸𝐒𝐆 and liquid and gas 𝜸𝐋𝐆. 
 
The contact angle of a liquid droplet on a solid surface can be described by Young’s 
equation, Equation (2.16) first proposed by Thomas Young in 1805. (108) The 
contact angle is defined by the mechanical equilibrium of droplet under the action of 
three surface tensions: solid-liquid, liquid-gas and solid-gas. 
 𝛾SG =  𝛾SL +  𝛾LG cos 𝜃 (2.16) 
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where 𝛾SG is the surface tension between solid and gas, 𝛾SL is the surface tension 
between solid, liquid and 𝛾LG is the surface tension between liquid and gas and 𝜃 is 
the contact angle. 
The opposite process compared with the wetting of water droplet on the solid 
surface is dewetting, which is the process that occurs at a solid-liquid or liquid-liquid 
interface. Dewetting describes the rupture of a thin liquid film on the substrate, 
which could be either a liquid or a solid, and the formation of a droplet. In this thesis, 
we focus on the liquid-liquid dewetting process, for example, the dewetting of a drop 
of oil placed on a water liquid phase, which can be determined by the parameter 
called the spreading coefficient (S). The oil-water system is displayed in Figure 2.13 
and the spreading coefficient can be calculated based on Equation (2.17). 
 𝑆 =  𝛾WA − (𝛾WO + 𝛾OA)  (2.17) 
in which 𝛾WA is the surface tension between water and the ambient gas phase, 𝛾WO 
is the surface tension between water and oil liquid phase and 𝛾OA is the surface 
tension between oil and gas phase. When S is a positive value, the spontaneous 
spreading of oil on the water surface occurs, whereas if S is negative a dewetting 
process between oil and water liquid phase occurs. 
 
Figure 2.13 Schematic demonstration of the displacement of an oil droplet on 
a water surface is represented by the spreading coefficient (S). When S > 0, 
droplet spontaneously spreads on the surface forming a layer, whereas S < 0, 
dewetting occurs with forming an oil lens on the water surface. 
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In microfluidic device, in order to form the double emulsion droplets, either water-
in-oil-in-water or oil-in-water-in-oil, with desirable lifetime requires that the middle 
phase wets the inner core completely. When this is not the case, a dewetting of the 
shell occurs with consequent disruption of the double emulsion droplets. 
Interestingly the dewetting between the inner core and the outer shell of a double 
emulsion droplet has been exploited as a transition process for the preparation of 
polymersomes. (109-112) Figure 2.14 illustrates the mechanism of dewetting 
transition between the inner and the middle phase and the formation of a thin bilayer 
of copolymer dispersed in the middle phase. In the system the coefficient S is 
described as in Equation (2.18). 
 𝑆 =  𝛾IO − 𝛾IM − 𝛾MO (2.18) 
where 𝛾IO , 𝛾IM  and 𝛾MO  are respectively the surface tensions between the inner-
outer interface, the inner-middle interface and the middle-outer interface. 
 
Figure 2.14 Dewetting of the middle volatile organic phase, from the aqueous 
core, of a double emulsion droplet dispersed in a water based solution (water-
in-oil-in-water). Copolymer molecules are dissolved in the middle phase. 
Dewetting event allows the formation of a bilayer of copolymer. 𝜽  is the 
contact angle at the three-phase contact point. 
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Chapter 3 Microfluidic Assembly of  
Lipid/Block Copolymer Vesicles as Artificial 
Cells Models 
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In Chapter 3, a microfluidic method of fabrication of lipid vesicles (liposomes) and 
polymeric vesicles (polymersomes) with thin-shells, in order to resemble natural cell 
structures is presented. Using the biphasic microfluidic device, highly uniform 
double-emulsion droplets with ultra-thin membrane were generated to recreate 
artificial cell chassis for the study of in vitro transcription-translation (IVTT) reaction 
and integration of transmembrane protein into artificial biomembranes. To mimic 
the architecture of natural cell compartment, the IVTT reaction of enhanced green 
fluorescent protein (EGFP) was performed with a novel cell-free translation system 
called PURE (Protein Synthesis Using Recombinant Elements) inside the vesicle 
systems. Moreover, the unilamellar vesicles assembled by microfluidics supports 
functional insertion both of purified and of in situ expressed transmembrane proteins. 
3.1 Introduction 
3.1.1 Lipid Vesicles (Liposomes) 
Lipid vesicles, also known as liposomes (113) are vesicular structures composed of 
self-assembled phospholipids encapsulating a volume of aqueous medium, which are 
considered as models for investigating the physical nature of membranes. (114-117) 
Phospholipids are amphipathic molecules that contain two components with 
different water solubilities. One moiety is the hydrophilic group, referred to as the 
polar head, while the hydrophobic segment, the non-polar tail region. A typical lipid 
molecule can be seen in Figure 3.1. 
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Figure 3.1 Space filling diagram of DOPC, a polar (hydrophilic) headgroup 
region consists of a glycerol backbone (A) and the hydrophobic non-polar 
tailgroup region (B); (C) depicts a single DOPC molecule composed of two 
major sections: a hydrophilic head (red) and hydrophobic tails (yellow); (D) 
displays a resultant lipid bilayer self-assembled with phospholipid molecules 
with a hydrophobic core; (E) demonstrates a simplified resultant lipid vesicles 
with an aqueous core and hydrophobic bilayer membrane. A single bilayer is 
typically ~ 5 nm thick and composed of neatly arranged individual lipid 
molecules with their “water-hating” tailgroups facing each other and their 
polar headgroups facing toward the interior and exterior aqueous medium. 
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Lipid vesicles can fall into several categories, most frequently classified by their size 
and lamellarity: (118, 119) (i) multilamellar vesicles (MLVs), (ii) small unilamellar 
vesicles (SUVs), (iii) large unilamellar vesicles (LUVs) and (iv) giant unilamellar 
vesicles (GUVs). These vesicles are schematically depicted in Figure 3.2. 
 
Figure 3.2 Schematic representation of the difference in the number of layers 
(lamellarities) and relative size of various types of lipid vesicles. The image is 
taken from (118). 
 
Lipid vesicles are excellent structures to entrap small compounds due to their ability 
to isolate the ingredients in interior of the vesicles from the external aqueous 
medium, providing a small volume of environment for reaction of those compounds. 
Nature takes advantage of the self-assembly mechanism and encapsulation property 
to enable formation of biological cells, where important biological processes take 
place within the phospholipid vesicles. (119, 120) As a result of resemblance of the 
vesicular structure to biological membranes, giant unilamellar vesicles (GUVs) have 
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served as attractive models of minimal cells because they exhibit a set of features: 
namely size, lamellarity, and the ability to control the lumen content (which closely 
mimics the structural organisation of living systems). This makes GUVs the platform 
of choice for a number of simplified, model cellular processes such as 
compartmentation (121, 122) phase behaviour of lipid bilayer, (80, 123) and 
membrane protein insertion into lipid bilayers. (124-127) 
3.1.2 Polymeric Vesicles (Polymersomes) 
Phospholipids are compounds nature uses to form barriers within living cells. They 
are also used in artificial lipid chassis. In biotechnology, there is another class of 
synthetically artificial vesicles, polymeric vesicles, or polymersomes. (128-131) 
Polymersomes are hollow spherical compartments, delimitated by a membrane of 
amphiphilic block copolymers (BCP). Block copolymers are macromolecules 
comprising of two or more types of polymers and similar to naturally occurring lipids. 
They are amphiphiles in which there is at least one fraction (block) of each molecule 
is hydrophilic, whereas the other block is hydrophobic. In an analogous fashion to 
the phospholipids, block copolymers can also aggregate in aqueous media, producing 
vesicular structures, as depicted in Figure 3.3. (128, 132) 
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Figure 3.3 Schematic representation of self-assembly of amphiphilic diblock 
copolymer into polymeric vesicles, or polymersomes: (A) A diblock copolymer 
molecule with “water loving” section, or hydrophilic block and “water hating” 
section, or hydrophobic block; (B) Polymersomes formed by amphiphilic 
diblock copolymer; (C) Bilayer with hydrophobic blocks facing each other, 
forming the hydrophobic core derives from the polymersome membrane  
 
The use of block copolymers instead of phospholipids can be used to synthesise 
artificial vesicles and has attracted much attention due to the advantages of their 
chemical properties and mechanical stabilities of polymersomes over liposomes. In 
particular, polymersomes can be constructed by a huge variety of hydrophobic and 
hydrophilic blocks, (128) allowing the control of mechanical properties and 
permeability. (133)  
The diversity of chemical properties of polymersomes can be adjusted by modifying 
the building block chemistry to make polymersomes responsive, either to external or 
internal stimuli, in a controlled manner. (134) Thus, polymersomes are the 
biomimetic analogues of phospholipid vesicles revealing their ability to act as an 
alternative artificial cell model. (135) Owing to the higher molecular weight of 
building blocks, the membrane thickness can be at least ten-fold than that of 
liposomes, which makes polymeric vesicles “stronger” and more stable. In the liquid 
state, polymersomes are much stronger in their mechanical properties than lipid 
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vesicles, and are able to support much more membrane stretching. (136) 
Phospholipids can also be subject to oxidation, whereas polymeric vesicles could be 
synthesised by more stable blocks and can have significantly longer lifetimes. (137, 
138) All aforementioned advantages of polymersomes indicate that vesicles based on 
block copolymers could be more suitable as artificial cell chassis. 
3.1.3 Droplet-Based Microfluidic Fabrication of  Vesicular 
Structures 
As previously descried in Chapter one, the advances in microfluidic technologies 
with the capabilities of generating and manipulating small volume droplets in 
controlled manners have led to new routes for preparation of vesicles. (139, 140) 
With the variety of available techniques for production of microfluidic devices, the 
geometry of the devices can be easily customised, making it possible to explore 
diverse device design for forming vesicular structures. 
3.1.3.1 Phase Transfer 
One of the most well-established methods to transform droplets into vesicles uses a 
process referred to phase transfer. Matosevic et al. described an emulsion transfer 
method, which was fully integrated into a microfluidic device as shown in Figure 
3.4(A). (141) In this formation process, lipid stabilised water-in-oil droplets were 
formed which were then guided through a Y shape junction into a co-flow laminar 
aqueous stream. The key point in this paper was the use of a triangular post, 
positioned in the microchannel to mediate phase transfer, helping droplets to pick 
up a second single lipid layer at the laminar oil-water interface. This “push” process 
was disruptive, with only 1 – 5 % of droplets surviving as they crossed the interface. 
In Figure 3.4(B), Malsmstadt et al. exploited a PDMS microfluidic device to produce 
monodispersed water-in-oil droplets, which were then transferred through an oil-
water interface forming another lipid monolayer to reduce polydispersity of droplet 
size distribution. (142)  
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Recently, Chu et al. introduced a wetting-induced approach for droplet transfer to 
generate vesicular structures, Figure 3.4(C). (143) The dispersed aqueous phase was 
injected into a microchannel containing PEG-b-PLA diblock copolymer solution as 
continuous phase to generate uniform water-in-oil droplets. A second water phase 
was injected into device to form a laminar flow with diblock copolymer stabilised the 
interface. Due to the evaporation and diffusion of the volatile solvent – chloroform, 
leaving oil phase a hexane-rich solvent, which induced an attraction between 
monolayers on the droplets and the one at the interface. At this time, the 
combination of interfacial tensions became negative and the droplets entirely 
travelled across into interface producing vesicles with bilayers. 
 
Figure 3.4 (A) Schematic illustration of a device where droplet generation and 
subsequent droplet transfer occurs on chip with the aid of a triangular post; 
(B) Droplets are formed in a single microfluidic device, and then expelled 
above oil-water column to yield vesicles; (C) Schematic of the transfer of water 
droplets stabilised by PEG-b-PLA across an oil-water interface to produce 
polymersomes, and CLSM images of resultant diblock copolymeric vesicles 
dyed by FITC-dextran. Images taken from (141-143). 
 
3.1.3.2 Emulsion-Templating with Single Emulsions 
To form monodispersed single emulsions using two immiscible liquid phases can be 
readily realised in microfluidic device. This approach of droplet production can be 
applied for preparation of single emulsion-templated vesicles, as depicted in Figure 
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3.5. Lee et al. developed a method using microfluidic device and oleic acid to generate 
lipid stabilised water-in-oil single emulsions. These single emulsions were 
subsequently injected into an aqueous mixture consisting of ethanol and water. (144) 
The rapid dissolution of oleic acid in ethanol forces the phospholipids to rearrange 
around the emulsions to assemble into a vesicle with bilayer, Figure 3.5(A). Matosevic 
et al. also detailed another single emulsion-templated method offered the ability of 
controlling membrane composition as well as lamellarity of membrane of vesicles. 
(82) Single emulsions with a lipid monolayer were formed and entrapped 
subsequently in a single microfluidic device, and then one to three more lipid 
monolayers were individually deposited on the droplet templates as illustrated in 
Figure 3.5(B). 
 
Figure 3.5 (A) Preparation of single emulsion-templated vesicular models; (B) 
Asymmetric vesicles formed by the sequential deposition of individual 
monolayers based on single emulsion templates. Image modified from the 
indicated references. (82, 144) 
 
3.1.3.3 Emulsion-Templating with Double Emulsions 
Water-in-oil-in-water double emulsions can be routinely generated with excellent 
monodispersity and 100 % encapsulation efficiency using microfluidics. (145) 
Double emulsions are recognised as ideal templates for forming vesicles by having 
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building blocks dissolved in the membrane cores. In addition, double emulsions and 
vesicles share similar core-shell structures; thus, double emulsion droplets prepared 
by droplet-based microfluidics can be used to shed light on the development and 
generation of vesicles.  
Glass capillary microfluidic devices, developed by Weitz group were used to prepare 
lipid vesicles (39) and polymeric vesicles (146) transformed from double emulsion 
templates. In the oil phases, build blocks (phospholipids/block copolymer) were 
dissolved in the organic solvent mixtures to realise dewetting-induced bilayer 
formation. In Figure 3.6(A), lipid stabilised double emulsion were continuously 
produced in the device. As extra oil phases were removed from the membrane, owing 
to the dewetting process (stated detailed in Chapter 2), two lipid monolayers at the 
internal oil-water interface and external water-oil interface came together into a 
bilayer, eventually forming a vesicular shape.  
In order to reduce the toxicity and improve the biocompatibility of bilayer, Arriaga 
et al. demonstrated a novel microfluidic design based upon microcapillaries which 
can prepare double emulsions with ultrathin shells, implying relatively less organic 
solvent is trapped in the membrane, Figure 3.6(B). (147) The idea behind the 
microfluidic device is that a biphasic flow occurs in the injection capillary where inner 
aqueous phase flows in the centre of the capillary surrounded by the oil phase 
carrying phospholipid molecules (and which moves along with the inside wall of the 
injection capillary due to affinity of hydrophobic nature of surface). This enables the 
formation of double emulsions with nanoscale shells, and provides a promising 
platform for vesicles generation (with the potential to broaden their application in 
biomedical research areas).  
Recently, Deshpande et al. reported the formation of monodisperse, cell-sized (5 – 
20 µm) unilamellar lipid vesicles via the formation of double emulsion drops with 
lipid molecules dissolved in 1-octanol as the intermediate phase. After the one-step 
formation of double emulsion drops in a flow-focusing microfluidic geometry, the 
double emulsion drops spontaneously develop a Janus geometry with a side-
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connected 1-octanol pocket because of dewetting. The 1-octanol segment eventually 
splits off, yielding fully assembled liposomes within 1 - 5 minutes that do not contain 
any non-desirable organic solvent in the bilayer, Figure 3.6(C). (148) 
 
Figure 3.6 (A) Microfluidic fabrication of phospholipid-stabilised double 
emulsions in a glass capillary device. Optical images of double emulsions 
with solvent shell containing phospholipid molecules and schematic of 
dewetting process for solvent removal from the shell; (B) Microfluidic 
preparation of double emulsion drops with ultrathin shells. Optical images of 
collected double emulsion drop template; the formation of lipid bilayer via 
dewetting process; the resultant lipid vesicle; (C) Schematic of working 
principle of microfluidic device. Fluorescence images showing steps 
corresponded to each of step described in the working principle. Temporal-
resolution sequences showing the separation of the 1-octanol droplet from the 
lipid vesicle.  
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3.1.4 In Vitro Transcription and Translation in Artificial Cell 
Models 
Transcription and translation is a conserved biochemical process shared across all 
life classes. The transcribing of a DNA template to messenger RNA (mRNA), 
followed by translation to a defined protein sequence is integral to all life, and thus 
has become known as the central dogma of molecular biology, (149, 150) as shown 
in Figure 3.7. Thus, to demonstrate the potential and to prove emulsions templated 
vesicles’ compatibility with biomolecules and their applications as artificial cell 
models, it is of importance to show that they can perform this process. (16, 151-153) 
 
Figure 3.7 The central dogma of molecular biology. DNA is first transcripted 
to messenger RNA. mRNA is translated to yield a protein with defined amino 
acid sequence. 
 
It has been demonstrated that the individual components for transcription and 
translation can be extracted from bacterial cells and then purified. (154) During an 
incubation period of several hours, these components can only be reacted with a 
DNA templates, either in plasmid vectors form from cloning or as a liner PCR 
(polymerase chain reaction) fragments for cell-free protein synthesis, especially those 
that are toxic to cells. However in recent years, cell-free expression machinery as an 
alternative to in vitro expression has expanded its use to in vitro compartmentalisation 
in synthetic biology, especially in artificial cell engineering. (155) 
Cell-free protein synthesis technology has been known about since 1961 and was 
first used by Nirenberg and Matthaei to decipher the genetic code. (156) Cell-free 
translation system containing ribosomal machinery and reagents required for protein 
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synthesis in conjugation with DNA sequence are increasingly being considered as 
viable alternatives for translation of essentially every protein. Using cell-free systems, 
activation of biological machinery can be achieved without cell integrity for protein 
expression to occur. In particular, the open reaction environment allows for the 
addition or removal of substrates for protein expression, as well as precise, online 
reaction monitoring. Importantly, the nature of cell-free protein synthesis enables 
shortened protein production timelines and increased flexibility for the addition or 
removal of natural or synthetic components compared with in vivo methods. Overall, 
cell-free protein synthesis holds promise to be a powerful technology platform for a 
new and rapidly developing field of synthetic biology – building synthetic cells. (13, 
115) 
Given that the concept that translation is one of the central cellular processes 
required for life, and the product of the cell-free expression system, proteins which 
are main component of the multiple cellular function, cell-free protein synthesis 
system (cell-free transcription-translation) have been broadly utilised in the 
development of synthetic cellular system. (115) Yu demonstrated the first liposome 
compartmentalised cell-free expression to synthesise a green fluorescence protein 
(GFP) within liposomes with binary compositions (egg phosphatidyl choline; 
cholesterol) in the bilayer. (157) As fluorescent proteins are readily detected using 
basic fluorescence microscopy, other GFPs such as red-shifted GFP and enhanced 
GFP (EGFP) have been created effectively to be exploited in the cell-mimetics. 
Following this first attempt of protein expression within liposome, synthesis of GFP 
in artificial cellular entities, it has demonstrated that the cell-mimetic environments 
(liposomes, water-in-oil single emulsions, water-in-oil-in-water double emulsions, 
coacervates) are compatible with biomolecules and can satisfy the prerequisite for 
constructing functional cell, which is in situ generation of complex biological 
structures. (16, 151-153, 158-163) Cooper and his team performed cell-free protein 
synthesis within water-in-oil single emulsions, (164) water-in-oil-in-water double 
emulsions (165) and polymersomes respectively (112) to study the preference to 
localisation of an actin-like bacterial cytoskeletal protein MreB at the membrane 
interface as well as osmotic-pressure triggered release of protein from polymersomes.  
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Additionally, cell-free protein translation machinery has been successfully 
compartmentalised in synthetic cells to express membrane proteins, such as 
nanometre-size pores, (16, 82) and  ion channels and transporters. (166-168) Having 
these complex membrane proteins expressed in the interior of compartments and 
reconstituted into membranes, the functioning synthetic cellular system can be 
eventually achieved realising idea of mimicking cells exist in nature. 
3.2 Materials and Methods 
3.2.1 Materials 
Double emulsion droplets templated vesicles were prepared using a capillary 
microfluidic device comprised of three cylindrical glass capillaries of 1 mm in outer 
diameter (World Precision Instruments, Inc., IB100-6, USA) tapered and nested 
within a square capillary of 1.05 mm inner dimension (AIT Glass, USA). 
Cylindrical injection capillary was treated with Sigmacote (Sigma-Aldrich, USA) while 
the cylindrical collection capillary was treated with 2-
[Methoxy(polyethyleneoxy)propyl]-trichlorosilane, (Fluorochem Ltd.). 
The innermost aqueous solution contained a cell-free protein synthesis solution 
(PURExpress, New England Biolabs) and plasmids coding for EGFP and α-
hemolysin respectively. The middle oil phases were a mixture of chloroform (Sigma, 
USA) and hexane (Sigma, USA) with a volume ratio of 36:64 with 5 mg/ml of 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC) (Sigma-Aldrich, USA) or triblock 
copolymer poly(2-methyloxazoline-b-dimethylsiloxane-b-2-methyloxazoline) 
(PMOXA-b-PDMS-b-PMOXA) (Polymer Source, Canada). The continuous phase 
was watery solution of 10 wt% PVA (Mw = 13000-23000, Sigma-Aldrich, USA) and 
0.5 M NaCl with 1100 mOsm/l while collection buffer was an aqueous solution of 
0.55 M NaCl which balances the osmolarity as inner aqueous phase. A water-soluble 
green dye - calcein (Sigma, USA) was used as a model active material for the dye 
release experiments. The pore-mediated dye leakage was conducted using α-
 
 
60 
 
hemolysin from Staphylococcus aureus (Sigma). Osmolarities were measured using 
an osmometer (3300 Micro-Osmometer, Advanced Instruments, Inc., UK). Fluids 
were manipulated by syringe pumps (Harvard Apparatus, USA).  
The generation of double emulsion droplets was observed using a high-speed camera 
(Vision Research Inc.). The expression of EGFP and the triggered release of the 
calcein by incorporating with nano-pore forming protein were evaluated by a 
confocal laser scanning microscope (LSM 510 META, Carl Zeiss, Germany). 
3.2.2 Preparation of  Solutions 
In order to prove the vesicles’ compatibility with biomolecules as cell mimics, double 
emulsion droplets templated vesicles were used as cell-like bioreactors to perform in 
vitro transcription and translation (IVTT). Vesicles filled with cell-free gene 
expression solutions were created using mixtures of PURExpress cell-free reagents 
and plasmids as inner water phase. This innermost aqueous phase was kept on ice 
until it was loaded into the syringe. Membrane building blocks, either as phospholipid 
or triblock copolymer, were dissolved in a mixture of chloroform and hexane (36:64 
vol%) at a concentration of 5 mg/ml for the middle phase of double emulsion 
droplets. Prior to loading middle phase into the glass syringe, the solution was 
sonicated for 30 minutes to assure amphiphiles were dissolved in the organic solvent 
mixture. A 10 wt% PVA aqueous solution was used as the continuous phase of 
double emulsions.  
3.2.3 Fabrication of  Microfluidic Device 
The microfluidic devices were based on coaxial assemblies of cylindrical and square 
glass capillaries on glass slides demonstrated by Weitz group. (52, 169) Two 
cylindrical glass capillaries of 1 mm in outer diameter and 0.58 mm in inner 
dimension were tapered by axially heating and pulling the capillary using a pipette 
puller (Sutter Instrument Co, Model P-97, USA) to have precise orifices with size of 
40 µm. The inner dimeter of two tapered capillaries were polished using 3000 grade 
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sand paper to obtain inner dimensions of around 100 and 200 µm for the injection 
tube and collection tube respectively. 
The capillaries were assembled within a square capillary of 1.05 mm and the distance 
(ca. 100 µm) between the inner and collection capillary was controlled manually 
under optical microscope. Before nesting within the square capillary, the cylindrical 
injection capillary was dipped in with Sigmacote for 30 minutes to make it 
hydrophobic, while the round shape collection capillary was treated with 2-
[Methoxy(polyethyleneoxy)propyl]-trichlorosilane to render its surface hydrophilic.  
Both of the two cylindrical capillaries were inserted into the square capillary from its 
two opposite ends, which was placed on a glass slide. Another circular capillary was 
pulled to form two long and thin pipettes to obtain an outer diameter of around 200 
µm. One pulled capillary with small size tip was inserted into the open end of the 
cylindrical injection capillary and aligned using the optical microscope. Lastly, 
dispensing needles used as inlets of fluids were glued to the glass slide using a 
transparent 5 Minutes Epoxy (Devcon). 
3.2.4 Lipid/Polymer Vesicles Preparation 
Ultrathin shell double emulsion templated liposomes or polymersomes were 
prepared using a glass capillary microfluidic device. The injection capillary with 
smaller size of tip was used to inject the purified E. coli extract, required for protein 
synthesis, with plasmids coding for different types of proteins; this formed the inner 
aqueous core of the vesicles. As middle phases, a mixture of chloroform and hexane 
was used with either DOPC or triblock copolymer (PMOXA-b-PDMS-b-PMOXA). 
This mixture was injected through the interstices between two injection capillaries 
forming the plug-like water in oil droplets. The continuous phase was a water phase 
of 10 wt% PVA and 0.5 M NaCl pumped through the interstices between the 
injection capillary and outer square tube. 
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The innermost, middle and outer phases were injected into the microfluidic device 
at flow rates of 500, 400 and 3000 µl/h respectively. Double emulsion droplets with 
thin membranes were collected in a glass vial containing water solution of 0.55 M 
NaCl solution. 
3.2.5 Cell-Free Proteins Expression within Vesicles 
The plasmids containing EGFP and α-hemolysin sequences respectively were kindly 
provided by Mr. Ross Eaglesfield. Single plasmid of EGFP were used for protein 
expression both in bulk and in vesicles. Experiments in bulk were useful to examine 
the design of the synthetic plasmid. 
A novel cell-free transcription-translation system named PURExpress (154) (New 
England Biolabs, USA) was used in all in vitro transcription and translation 
experiments in this thesis. The system was reconstituted from the purified 
components necessary for E. coli protein expression. It is a one-step reaction which 
simply requires mixing of two tubes of solutions with the template DNA. 
Conducting IVTT within cell-mimetic systems by means of using PURExpress 
system is becoming desired in the research of building synthetic cells. 
According to the protocol of PURExpress system, preparation of the cell-free 
protein synthesis solution is depicted in Figure 3.8. For individual experiment, 30 µl 
of solution B was added to 40 µl of solution A. 8 µl of plasmid, and 2 µl of RNase 
inhibitor (New England Biolabs, USA) were then added. Lastly, 20 µl of nuclease-
free water was added to the mix up to 100 µl total volume. The prepared solution 
was gently mixed by pipetting up and down three times. 
The solution was kept on ice until it was either loaded into a 100 µl glass syringe 
(Hamilton, CH) or incubated in a 96-well plate (Fisher Scientific, USA) in plate reader 
(Synergy HT, BioTek) with a standard shaking incubation at 37 °C for 210 minutes. 
When double emulsion droplets were produced, they were collected into a glass vial 
for solvent evaporation for 10 – 30 minutes. Afterwards, 150 µl of the suspension of 
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vesicles was pipetted into a well on the glass slide (Marienfeld, Germany) and covered 
by a cover slip (20 × 20 mm) for incubating at 37 °C for 3 hours in a temperature 
controlled pad (Tempcontrol 37-2 Digital, Meyer Instruments). 
 
Figure 3.8 Schematic illustration of preparation of cell-free protein synthesis. 
This was made of designed plasmid coding for proteins of interest, 
PURExpress solutions A and B, supplements and nuclease-free water. 
 
3.3 Results and Discussion 
3.3.1 Lipidic/Polymeric Vesicles Generation 
A glass capillary microfluidic device was used to fabricate double emulsion drops 
with ultrathin membranes, as illustrated in Figure 3.9(A). We used innermost smaller 
capillary to inject aqueous phase of 8 wt% PEG and 2 wt% PVA, into the left tapered 
capillary; the PEG enhanced the contrast between inner and outer aqeous phases as 
well as the viscosity of the solution, while the PVA enhanced the stability of the 
double emulsion drops. We treated the left tapered injection capillary to be 
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hydrophobic, thus preventing wetting of the innermost aqueous phase on the 
capillary wall. We used this tapered capillary to inject the middle oil phase, DOPC 
dissolved in a mixture of chloroform and hexane in which their volume ratio was 
36:64; the total lipid concentration was 5 mg/ml. We injected innermost aqueous 
phase and middle oil phase at flow rate of 500 μl/h and 400 μl/h, respectively; under 
these conditions the innermost aqueous phase formed large water in oil emulsion 
drops within the left tapered capillary, as exemplified in the schematic illustration in 
Figure 3.9(A). We then injected the outer aqueous phase, a 10 wt% PVA solution, 
through the interstices between the left tapered capillary and the square capillary, at 
flow rate of 3000 μl/h. We treated the right tapered capillary to render its surface 
hydrophilic, therefore preventing wetting of the middle oil phase on its wall. To 
prevent osmotic stresses, we collected the double-emulsion droplets in a glass vial 
containing 50 mM NaCl solution having the same osmolarity as the inner watery 
cores. Importantly, the unwanted residual oil droplets formed within the device due 
to the excess lipid phases between two water-in-oil droplets can be easily removed 
from lipid vesicles samples by exploring the density differences in the solution 
systems, Figure 3.10. 
Highly uniform thin-shell double emulsions were prepared using the microfluidic 
device at high-throughput, and then collected and imaged as shown in Figure 3.9(C). 
The thin shelled double emulsion droplets were featured with the enhanced stabilities 
as a result of reducing the thickness of the middle layer until reaching the lubrication 
regime. (170) Thus, lipid vesicles produced by transforming from ultrathin shell 
double-emulsion droplets at a higher yield ratio compared to the liposomes prepared 
by thick membrane double emulsions. (147) These double emulsions have two 
concentric interfaces which enable the direct formation of a bilayer. The formation 
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Figure 3.9 Microfluidic production of lipid vesicles from thin-shell double 
emulsion templates: (A) Schematic illustration of microfluidic device for 
fabrication of double-emulsion droplets with thin shells. Scale bar is 200 µm; 
(B) Schematics of a produced lipid vesicle; (C) Optical microscope image of 
the microfluidically prepared double emulsions. Scale bar denotes 200 µm; (D) 
CLSM image of as-formed lipid vesicles with bilayers labelled with 
Rhodamine-PE. Scale bar is 20 µm. 
 
of the bilayer was induced by the dewetting process. The lipid molecules were 
dissolved in middle oil phase consists of a mixture of highly volatile good solvent 
(chloroform) for lipids and a less volatile poor solvent (hexane), double emulsions 
exhibited dewetting of the middle phase containing the lipids during evaporation.  
Initially, in membranes of double emulsion, lipid molecules occupied both inner and 
outer interfaces, which helped to keep the construct intact. As the good solvent 
preferentially evaporated, the poor solvent was concentrated and was expelled from 
the dense array of lipid molecules at the inner and outer interfaces, resulting in two 
lipid monolayers stick together forming a lipid bilayer membrane, Figure 3.9(D). The 
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expelled poor solvent droplets floated in the glass vial due to their lower density and 
were easily removed by pipetting as shown in Figure 3.10. Importantly, the middle 
layers of double emulsion templates were very thin, complete dewetting transition 
required a shorter time. 
 
Figure 3.10 Oil removal from lipid vesicles samples by applying density 
differences of solutions. Density: Lipid vesicles > Collection solution > Oil 
droplets. 
 
Polymersomes are alternative cell mimicking models, Figure 3.11(A). The triblock 
copolymer, PMOXA-PDMS-PMOXA, has been widely studied to form polymeric 
flat membranes and vesicles as a result of fluidity nature of PDMS for mimicking cell 
membrane. (171, 172) In between two hydrophilic blocks is the hydrophobic central 
block, forming the similar membrane structure as the membrane comprised by lipid 
chain groups. Due to molecular structure of the triblock copolymer, it can have two 
morphologies in the resultant membrane, depending on the disposition of the two 
hydrophilic parts on the two sides, I-Shape, Figure 3.11(C) or on the same side of 
the hydrophobic layer, U-Shape, Figure 3.11(D). (173, 174) By utilising the same 
microfluidic strategy, Figure 3.12(A), thin-shell double-emulsion templates for 
constructing polymersomes were produced. The double emulsions were 
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monodisperse in size and efficiently encapsulate the fluorescent dye (calcein) as 
shown in Figure 3.12(B, C). The typical coefficient of variation (CV), in size is lower 
than 4 %. In Figure 3.12(C, D), there was the cross talk occurred between calcein 
and Nile Red as the overlap in their spectrums of two fluorophores originated by the 
setting of fluorescence filters. 
 
Figure 3.11 Cell-like structure in the form of polymersome: (A) Schematics of 
polymeric vesicular structure; (B) Membrane building block: PMOXA-
PDMS-PMOXA, triblock copolymer as an analogy to lipid molecules. Two 
PMOXA chains are ‘water loving’, in between is the PDMS block which is 
hydrophobic; (C) Membrane in I-shaped conformation; (D) Membrane in U-
shaped conformation. 
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Figure 3.12 Production of polymersomes from thin shelled double emulsion 
droplets: (A) Schematic demonstration (top) of microfluidic approach for 
making double emulsions with ultrathin membranes. Optical micro-image 
(bottom) of generation process. Scale bar is 200 µm; (B) Optical microscope 
image of monodisperse double emulsion droplets. Scale bar denotes 200 µm; 
(C-E) CLSM images of as-formed polymersomes. Scale bars are equal to 100 
µm; (C) Green channel: calcein encapsulated inside polymersomes; (D) Red 
channel: polymeric bilayers labelled with 0.5 mol% Nile Red; (E) Merged 
channel: interior aqueous phase enclosed by a polymeric membrane. 
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3.3.2 Protein Expression in Lipid Vesicle Based Artificial Cells 
This microfluidic method enables exceptional robustness, flexibility and 
controllability, and results in monodisperse artificial cell chassis. To demonstrate the 
potential as cell-mimic systems and to prove their biocompatibility, we performed 
the in vitro transcription and translation within both liposomes and polymersomes. 
Prior to microfluidic encapsulation of synthetic plasmids for targeted proteins 
together with cell-free expression solution to undertake gene-directed protein 
synthesis in lipidic or polymeric microcompartments. The water-soluble fluorescent 
protein EGFP was expressed in bulk solution to validate successful plasmid design 
by monitoring fluorescent protein synthesis using a plate reader. This was done to 
investigate if the signal was intense enough to be detected when showing IVTT in a 
vesicle format. To do this, the cell-free protein synthesis mix was prepared as 
previously described. The synthetic plasmid was added into IVTT solution 
respectively, and pipetted into a well on a 96-well plate. One more portion of cell-
free mix solution without the plasmid used as a control was added into another well 
as well. The plate was incubated at 37°C for 210 minutes, and the expression levels 
of EGFP synthesis were read every 5 minutes using a standard FITC filters. 
Increase in EGFP fluorescence indicated successful expression of the protein by cell-
free synthesis, as shown in Figure 3.13. In the first 2 hours, fluorescence signal curve 
of EGFP shows an increasing trend with time. After 2-hour expression, the 
fluorescence signal reached a plateau. 
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Figure 3.13 The expression kinetics of the IVTT of EGFP in bulk recorded by 
a plate reader. 
 
The ultrathin shell double emulsions templating route to form a large number of 
monodisperse lipid vesicles with high encapsulation efficiency provides excellent 
models entrapping biomolecules which could be cell-free expression systems within 
membrane-bound compartments, mimicking the ‘cytosol’ of artificial cells. Lipid 
vesicles were employed as cell-like bioreactors to perform in vitro transcription and 
translation (IVTT). Lipid vesicles filled with PURExpress cell -free gene expression 
solutions were successfully created as inner water phase to prepare loaded liposomes. 
The collected double emulsion droplets were left at room temperature for 10 – 30 
minutes in order to allow the complete dewetting transition and sedimentation of 
liposomes, and then they were incubated at 37°C and monitored for 3 hours by 
confocal laser scanning microscopy (LSM 510 META, Zeiss). Images were captured 
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every 5 minutes in which expression levels were analysed by the supplied Zeiss 
software. As Figure 3.14(A1 – A3) shows, the fluorescence intensity of EGFP in 
liposomes notably increased from 0 to 85 minutes. In the first 85 minutes, Figure 
3.14(B), the fluorescence signal increased linearly and then reached a plateau after 3-
hour expression, probably because of exhaustion of the nutrients required for the 
protein synthesis. This data was consistent with other kinetic studies performed on 
PURExpress cell-free protein formation. (152) A difference in reaction kinetics can 
be seen in between bulk and cell-like compartments might due to the 
macromolecular crowding within the aqeous phase that facilitates the recation rate 
of the cell-free expression. As such we demonstrated that our lipid vesicles can act 
as compartments for cell-free gene expression which is a step forward in making an 
artificial cell from bottom-up. 
 
Figure 3.14 IVTT of EGFP in lipid vesicles: (A1 – A3) Sequence images show 
expression of EGFP inside the liposomes; (B) The corresponding expression 
kinetics. (n = 15). 
 
3.3.3 Protein Insertion into Polymersomes 
In order to demonstrate that the membranes of polymersomes formed in our 
method can be a promising analogues to lipid bilayers and to show the feasibility of 
engineering the properties of such membranes, we performed cell-free expression of 
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a pore-forming protein, α-hemolysin (αHL), (175) and the pore-mediated transport 
of molecules across polymeric boundaries. 
We first prepared polymersomes loaded with PURExpress cell-free expression 
solutions with the synthetic plasmid coding for αHL and 10 µM of calcein fluorescent 
molecules, and observed the fluorescence intensity in polymersomes over time, 
Figure 3.15(A). The performance of IVTT was measured in the same manner as lipid 
vesicles. The αHL-induced transport is shown in Figure 3.15(B1 – B3). Once the 
monomers of αHL were expressed inside polymeric compartments and assembled 
nanopores in the membranes, the dye in the polymersomes rapidly diffused into the 
external environment.  
In Figure 3.15(C), we observed that the membrane proteins were incorporated into 
the membranes from 60 – 65 minutes since the incubation started, which caused the 
dramatic decrease of fluorescence intensity. While a slight decay in fluorescence was 
found in the first hour which was a consequence of photobleaching. To further 
confirm the incorporation of membrane proteins into the polymersomes, αHL (20 
µg/ml) was added into the suspension of as-formed polymersomes loading calcein 
(10 µM) within inner aqueous phase, and observed the fluorescence intensity leakage 
over the time course, Figure 3.16(A).  
In Figure 3.16(B1 - B3, C), we similarly observed fluorescent molecules leakage over 
~20 minutes since the addition of αHL at 5 minutes. In contrast, in the absence of 
αHL, there was no significant reduction of the fluorescence intensity can be seen. 
Consequently, these results demonstrated the biological relevance of these polymeric 
bilayers with thicker membranes compared with lipid bilayers in supporting insertion 
and assembly of a pore-forming membrane protein. Additionally, loading the vesicles 
with genetic materials and in vitro transcription and translation system provided 
evidence that corroborates the produced polymeric microcompartments can serve as 
the synthetic cell models on which to display the integration of highly functional 
membrane proteins. 
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Figure 3.15 Membrane protein synthesis and function in polymersomes: (A) 
Schematic diagram and (B1 – B3) confocal image series show polymeric 
vesicles loaded with DNA that encodes the αHL gene, cell-free expression 
solution, and calcein were incubated to allow an IVTT of αHL monomers, 
membrane incorporation of monomers and pore assembly and function; (C) 
Kinetics of time-dependent loss of calcein fluorescence due to the expression 
of αHL (n = 4). 
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Figure 3.16 Reconstitution of nano pore-forming protein into polymersomes: 
(A) Schematic diagram and (B1 – B3) confocal image series show αHL pore-
mediated transport of fluorescent molecules; (C) Kinetics of time-dependent 
release of calcein fluorescence (n = 7). 
 
3.4 Conclusion 
In this Chapter, we have shown a microfluidic route based on glass capillaries to 
form monodisperse liposomal and polymersomal structures by using ultra-thin shell 
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double emulsion droplets as the templates. These thin-shelled double emulsions 
droplets were constructed with thin layer of organic solvent in the membranes as a 
result of the biphasic flow mechanism in the injection capillary. By inducing the 
dewetting transition in the membranes, the organic solvent evaporated, assisting to 
form either lipid bilayers or polymeric bilayers. 
It was shown that IVTT can take place within the produced vesicle-based artificial 
cell models. EGFP, the water-soluble fluorescent protein was cell-free expressed 
inside lipid vesicles. The linear increase of fluorescence intensity caused by expressing 
EGFP was clearly seen, which confirmed that the constructed lipid vesicles were 
successfully applied as bioreactors to perform the protein synthesis that is a key 
reaction occurs in natural cells. 
Polymeric vesicular compartments were also formed by using the same microfluidic 
technique. To the best of this author’s knowledge this is the first generation of 
polymersomes composed of PMOXA-b-PDMS-b-PMOXA, which were widely 
studied as the best candidate to produce polymersomes using conventional methods. 
(176) To further investigate the polymeric membrane property, a pore-forming 
protein induced fluorescent molecules diffusion across the polymeric boundaries was 
shown, which relied on the incorporation of the membrane proteins into polymeric 
membranes. IVTT was also performed in our polymeric compartments. The 
synthesis of αHL within the aqueous core of the polymersomes inserted into the 
polymersomes and triggered a remarkable decrease of fluorescence intensity that was 
consistent with the assembly of pores in the bilayers by adding monomers into the 
external solution. These experiments showed that vesicle-based artificial cells, 
liposomes and polymersomes, produced by microfluidics offered the great models 
to deepen our understanding of certain functions of living cells, like cell-cell and cell-
environment commutations via functional membrane-associated proteins. 
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Chapter 4 Mapping Viscosity in Thin-Shell 
Double Emulsion Templated Lipid Vesicles by 
FLIM 
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Chapter 4 describes the use of the molecular rotor based on meso-substituted boron-
dipyrrin (BODIPY) in combination with fluorescence lifetime spectroscopy for 
mapping viscosity within artificial bilayers of lipid vesicles fabricated by 
microfluidics. The aim is to investigate the viscosity of the artificial membrane 
environment generated from microfluidic interfaces as model lipid bilayers. This will 
enable us to visualise the membranes of the synthetic cell chassis using fluorescence 
lifetime image microscopy (FLIM), determining their associated viscosity values. In 
the future such data may enable us to determine the potential of using these systems 
to build functional cell-mimetic systems by incorporating channels into artificial 
bilayers. 
4.1 Introduction 
4.1.1 Membrane Fluidity 
The cell membrane (or plasma membrane) is made up of a complex fluid-like 
structure of various phospholipids, proteins and cholesterol. (177, 178) It fulfils two 
important roles during the entire of lifespan of the cell in: (i) maintaining the physical 
integrity of the cell i.e. to mechanically delimitate the cell from its external 
microenvironment; and (ii) control the movement of particles (endocytosis and 
exocytosis of large of particles) and thereby regulate the exchange of substances 
between internal and external media. (179) One of the key physical parameters of the 
biomembrane is its fluidity, which determines the ease with which phospholipids are 
able to travel in the plane of the bilayer. (180-182) It is widely accepted that 
membrane fluidity acts a pivotal part in cellular functions, such as endocytosis, 
membrane fusion and cell signalling. (183) Also, changes of this intrinsic property of 
the biomembrane have been linked to various diseases. (182, 184-190) 
4.1.2 Conventional Methods to Measure Membrane Fluidity 
There are various techniques for determining the membrane fluidity, which is the 
intrinsic property of fluid-like structure by observing either the rotational or lateral 
mobility of a tracer molecule incorporated into the membrane. Typically, membrane 
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fluidity can be measured with nuclear magnetic resonance spectroscopy (NMR), 
electron spin resonance (ESR) and fluorescence-based approaches. 
The measurement of micro-viscosity in vesicular bilayer has been studied by ESR 
spectroscopy. (191) In ESR, stable nitroxyl radicals as reporter molecules (spin 
probes) are widely used to characterise the bilayers microenvironment and 
membrane dynamics by measuring the rotational correlation time of the spin probes. 
(191) In addition, ESR is used as a means for quantifiable viscosity values in the 
bilayer environment at high spatial resolution, with the aim of exploring the 
significant area of liposomes in drug delivery. (192, 193)  
Similar to ESR, deuterium NMR spectroscopy, has been also commonly applied to 
examine membrane fluidity with deuterated lipids are conjugated into a membrane. 
(194, 195) In NMR spectroscopy, quantifiable information of membrane micro-
viscosity is acquired through the specific spectroscopic features result from the 
average carbon-deuterium bond orientation of the deuterated lipids. (178) In 
particular, with 2H-NMR the residual quadrupolar couplings are related to the 
segmented order parameters of the flexible phospholipid molecules in a liquid-
crystalline membrane system. (196) By utilising NMR, the structural and fluid 
information of a membrane can be simultaneously, non-invasively revealed at atomic 
precision. As a consequence of the heterogeneous nature of biomembranes, both 
ESR and NMR offer no insight into lateral differences in membrane viscosity values 
due to the fact that spectroscopy characteristics depend upon observation of the 
rotational dynamic of the tracer molecule. 
Lateral motions of molecules within the membrane can be probed by a number of 
fluorescence based methods. These techniques reply on incorporating of a selection 
of suitable fluorescent molecules with a broad range of wavelengths. (197, 198) 
Fluorescence recovery after photobleaching (FRAP) has been used to determine the 
diffusion coefficients or micro-viscosity in biological membrane. (199, 200) In a 
FRAP experiment, a membrane is fluorescently labelled with fluorescent probes as 
the first step, and then imaged with weak laser illumination. Subsequently a small 
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region, termed as the Region of Interest (ROI) is photobleached using an intense 
laser pulse. The bleached area is then imaged over time with a significantly reduced 
laser illumination to record the recovery of fluorescence signals, which results from 
the lateral diffusion of the phospholipid molecules into the photobleached spot. By 
monitoring the kinetics of fluorescence recovery with time, the diffusion coefficient 
of the fluorescent lipid or tracer probe within the membrane can be determined and 
corresponded to the lateral motion in the bilayer environment.  
FRAP is a simple and powerful technique for the analysis of lipid mobility in the 
larger membrane and generation of the maps of diffusion coefficient in a single spot. 
However, FRAP suffers from its lack of spatial resolution information which is of 
significance when investigating the membrane as a whole. (201, 202)  
Another ideal technique to study the lateral organisation of the membrane can be 
found in Fluorescence Correlation Spectroscopy (FCS). (203-205) Similar to FRAP, 
the application of FCS requires fluorescent labelling of the molecules of interest, and 
the measurement of membrane lateral heterogeneities are based on the fluctuations, 
which are given rise by the mode of lateral diffusion of the probe, in fluorescence 
intensity acquired from a diffraction limited observation volume. Positioning the tiny 
focal volume to the plane of the bilayer allows direct measurement of the translation 
mobility coefficient of a low concentration of fluorescent probes. (206) Recent 
research demonstrated that FCS equipped with higher spatial resolution (> 500 nm) 
is available that go beyond the resolution limit. (207) In spite of the fact that many 
technically-demanding FCS-based techniques are able to investigate the membrane 
lateral dynamics, in the most of cases only a tiny observation spot readout is possible 
and spatially-resolved information is inaccessible. 
4.1.3 Molecular Rotors 
The definition and prospect of molecular rotors was coined by the pioneer in 
nanotechnology Richard Feynman in his talk “There’s Plenty of Room at the Bottom” 
at an American Physical Society meeting in 1959. (208) Very recently, molecular 
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rotors have emerged to be a promising probe to shed light on quantifying the micro-
viscosity in biological systems, such as living cells and biomimetic cell models. (209-
212)  
The molecular rotors, specifically exploited in this thesis, are a class of synthetic 
viscosity-sensitive fluorophores in which fluorescent parameters, such as their 
quantum yield and fluorescence lifetime, are strongly correlated to the micro-
viscosity of their immediate environment. (75, 212) The sensitivity to viscosity of the 
molecular rotors originates through altering the non-radiative deactivation rate of the 
excited state in a viscous surrounding medium. This typically occurs due to a 
viscosity-dependent intramolecular structure change, such as twisting or rotation. 
(212) Upon exaction, the double bond decreases in bond order producing a bond of 
1, which becomes flexible to rotation. In the excited state that is barrierless for 
rotation, the rate of rotation can be described according to the Stokes-Einstein-
Debye relationship. 
 𝑘𝑟𝑜𝑡 =  
1
𝜃𝑟
=
𝑘𝐵𝑇
4𝜋𝑟3𝜂
 (4.1) 
Where 𝑘𝑟𝑜𝑡  is the rate of rotation, 𝜃𝑟  is the rotational-correlation time, 𝑘𝐵  is the 
Boltzmann constant (1.3806 × 10-23 m2 kg s-2 K-1), 𝑇 is the absoluate temperature, 𝑟 
is the radius of the molecule in metres and 𝜂 is the solvent viscosity in N s m-2.  
As reviewed in Chapter 2, the fluorescence lifetime is correlated to the sum of 
radiative and non-radiative rate constants. The most widely adopted class of 
molecular rotors are featured with Twisted Intramolecular Charge Transfer (TICT) 
excited states. (213) In the case of this particular type of rotors, intramolecular 
rotation is the leading basis of the non-radiative decay. Assuming 𝑘𝑛𝑟 = 𝑘𝑟𝑜𝑡, then 
Equation (4.1) can be rewritten by integrating Equation (2.1) to give Equation (4.2): 
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𝜏 =  
1
𝑘𝑟 +  
𝑘𝐵𝑇
4𝜋𝑟3𝜂
 
(4.2) 
In the above relationship 𝜏 is the fluorescence lifetime and 𝑘𝑟 indicates the radiative 
decay rate constant, and this relation delivers a connection between the fluorescence 
lifetime and the values of temperature and viscosity of the media. In additional to 
Equation (4.2), a more practical relationship between viscosity and fluorescence 
lifetime was described by Förster-Hoffmann model shown below. (214) 
 𝜏 =  𝐶𝑚 × 𝜂
𝛾 (4.3) 
where 𝐶𝑚 is the concentration-temperature constants and 𝛾 is the dye dependent 
molecular parameter, which is calculated from the slope of a straight line yield from 
a plot of a function of logarithm of fluorescence lifetime vs logarithm of viscosity.  
These values are obtained by measuring the lifetime of the molecular rotor in 
solutions with different mixture ratios, for example methanol-glycerol mixtures of 
increasing glycerol content corresponds to a higher viscosity. Various of fluorescent 
molecules highlighted with viscosity-sensitivity characteristic have been reported, 
such as retinol palmitate, (215) Hoechst 33258, (216) DCVJ, (213) and di-4-
ANEPPDHQ. (217) A type of fluorophore, meso-substituted boron-dipyrrin 
(BODIPY), has attracted scientists’ attention can act as a molecular rotor featured 
with strong correlation with the viscosity with sharp variations in its fluorescence 
quantum yield and lifetime. (209) The combination of this class of viscosity sensitive 
fluorophores with Fluorescence Lifetime Imaging Microscopy (FLIM) opens the 
door to highly resolved spatial mapping of local micro-viscosity in biological 
membranes. (209, 210, 212, 218) 
4.1.4 Giant Unilamellar Vesicles 
The cell is an active and exquisitely complex system and is difficult or even 
impossible to fully understand due to the wide variety of processes occurring, in 
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partnerships, at any one time. A variety of idealised systems and cell models have 
been created and synthesised to circumvent this problem. A promising candidate is 
a giant unilamellar vesicle (GUV), which provides cell-like structure with a confined 
volume of aqueous media. It can be used to study biochemical reactions as well as 
physical nature of the membrane. Membranes or bilayers in the form of giant vesicles 
have been utilised as controlled and flexible platforms for membrane research. 
Engineering of giant vesicles in wide range of size can be performed using 
electroformation, gentle hydration, extrusion or microfluidics. An example of 
compounds for self-assembly of bilayer and the categories of giant vesicles are treated 
in detail in Chapter 3.1.1. 
4.2 Materials and Methods 
4.2.1 Materials 
The phospholipids for experimentation were from stock samples purchased from 
Sigma Aldrich. 1, 2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) was purchased as 
lyophilised powders and subsequently dissolved in chloroform at 25 mg/ml. For 
microfluidically produced thin-shell lipid vesicles, DOPC was diluted at 5 mg/ml 
into a solvent mixture of chloroform and hexane with a volume ratio of 36:64 (Sigma). 
Microfluidic lipid vesicles were fabricated and collected using similar inner (PEG and 
PVA) and outer (PVA) aqueous solutions, and collection solution (50 mM NaCl) 
presented in Chapter 3. 
4.2.2 BODIPY Based Molecular Rotor 
The molecular rotor applied in the membranes in this study was a kind gift from Dr. 
Marina Kuimova who is from Imperial College London. The fluorescent molecule 
was synthesised as described in previous work by Dr. Marina Kuimova group. (210, 
219, 220) The molecular rotor, which is a substituted boron dipyrromethene 
(BODIPY) derivative, is depicted in Figure 4.1. The fluorescence spectrum is 
presented in Figure 4.2 and shows that the excitation and emission wavelengths are 
490 nm and 520 nm, respectively. 
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Figure 4.1 The chemical structure of the meso-substituted BODIPY 
molecular rotor (BODIPY-C10). 
 
 
Figure 4.2 The fluorescence spectrum of the BODIPY-C10 molecular rotor 
with phospholipid in chloroform. 
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4.2.3 Preparation of  Giant Unilamellar Vesicles 
4.2.3.1 GUV Electroformation 
The most popular method for GUV production is an electroformation technique 
firstly outlined by Miglena Angelova et al. (35) The underlying theory of creation of 
GUVs via electroformation relies upon applying an alternating electric field across 
hydrating lipid layers, leading to lipids reorganising into membrane buds and forming 
vesicular structures. Electroformation for the preparation of giant vesicles adopted 
was based on a standard protocol. (221) The desired lipid was made up to a final 
concentration of 3.75 mg/ml which used to generate a uniform lipid coating. The 
lipid was initially diluted at a concentration of 25 mg/ml in a solution of chloroform. 
The mixture was made up to a 1 ml solution of chloroform and acetonitrile with a 
volume ratio at 95:5. Prior to form the lipid films, the solution was stored in the 
freezer at -20°C for a few days.  
Clean indium tin oxide (ITO)-coated slides (30 × 30 mm) for electroformation were 
prepared by connecting with one copper wire secured with conductive paint to 
provide electrical contact. The conductivity of the ITO slides was obtained with a 
multimeter to measure the resistance, between the ends of the wire and the centre of 
the slides, and only those with < 40 Ω were used. These slides were then rinsed with 
methanol and blow dried using compressed nitrogen. The lipid solution was then 
spin-coated onto the conductive surface of the ITO slides, at a speed of 300 rpm for 
30 seconds to produce an even lipid coating across the entire slides. After spin-
coating, the lipid-coated slides were dried under vacuum for at least two hours to 
ensure the removal of all residual solvent exists within the lipid film.  
The ITO slides coated with lipid sheets were then separated from the conductive 
surface of another uncoated ITO by a rubber gasket, either a rubber O-ring or a 
PDMS block with an excised centre, and sealed with vacuum grease to form a sealed 
chamber for electroformation. The set-up for electroformaion was assembled as 
depicted in Figure 4.3(A). 
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Figure 4.3 (A) Electroformation set-up. Two surfaces of ITO slides (one with 
a lipid sheets) were separated by a rubber O-ring forming a chamber for 
electroformation. The chamber was filled with inner buffer of 100 mM sucrose, 
and an AC-field was applied to the surfaces of ITO slides to initiate 
electroformation; (B) Schematic of electroformation apparatus for the 
construction of DOPC GUVs. DOPC vesicular structures formed by budding 
off from the film of the conductive substrate. 
 
The electroformation experimentation requires two solutions which were used to 
control pH values and osmotic pressure as well as to provide a density gradient 
between inner and outer GUV environment. An interior buffer consisting of 100 
mM sucrose was used and an exterior collection buffer of 90 mM glucose and 10 
mM HEPES (pH adjusted to 7.4 using 25% KOH) was used to provide a sugar 
density gradient, which ensured that GUVs settled to the coverslip surface for 
investigation by optical microscopy. 300 µl of inner buffer (100 mM sucrose) was 
added into the chamber before sealing the ITO slides. For single phase (DOPC) 
GUVs electroformation, an AC-field electroformation pulse sequence was applied 
across the interior buffer-filled electroformation chamber, as displayed in Figure 
 
 
86 
 
4.3(B), and electroformation parameters used for DOPC GUVs was outlined in 
Table 4.1. 
Table 4.1 Electroformation pulse applied into the electroformation chamber. 
The voltage was ramped from 0.1 to 1.6 Vpp over the duration of 60 minutes, 
then maintained at 1.6 Vpp for a further 60 minutes, at the frequency of 10 Hz. 
This pulse sequence stimulated vesicles growth from the lipid-coated ITO 
slides. The 2.0 Vpp pulse applied for 60 minutes, at a frequency of 4 Hz with 
the aim to the detachment of GUVs from the slides. 
Pulse frequency 
(Hz) 
Pulse voltage 
(Vpp) 
Pulse shape Time (minutes) 
10 0.1 Sine 10 
10 0.5 Sine 20 
10 1.0 Sine 30 
10 1.6 Sine 60 
4 2.0 Square 60 
 
Once detached the DOPC GUVs were transferred into the 1 ml of glucose buffer at 
a concentration of 90 mM associated with 10 mM HEPES. This provided adequate 
distribution of DOPC vesicles over the surface of a coverslip to investigate single 
vesicle without interaction with other GUVs. For study of GUVs using FLIM the 
vesicle solution was gently pipetted to a microscope slide with a well and then sealed 
with a square coverslip which can cover the well space to ensure no evaporation of 
the buffer and no movement of solution caused by convection. 
4.2.3.2 Microfluidic Generation of GUVs 
DOPC vesicles templated by double emulsion droplets and thin shell were produced 
according to the detailed protocol described in Chapter 3.  The inner aqueous phase 
of PEG and PVA was pumped into the small injection capillary; and the BODIPY-
C10 molecular rotor was dissolved in the lipid middle phase at a concentration of 0.1 
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mol% (1:1000 molecular rotor : lipid), which was injected in the another injection 
glass tube. 10 wt% of PVA solution as outer fluid was pumped into microfluidic 
device through the interstice between the injection capillary and the square capillary. 
A glass vial containing collection solution was used to store the produced double 
emulsion droplets, in which dewetting process occurred aids the transformation of 
as formed lipid vesicles from double emulsion templates. 
For the exploration of membranes of as formed GUVs using FLIM, the vesicles were 
pipetted gently to a dished microscope slide with the tip-cut pipette tips reducing the 
shear forces applied to the GUVs. A coverslip was then sealed onto the microscope 
slide securing the vesicles within the well for the observation. 
4.2.4 Fluorescence Lifetime Data Analysis 
All fluorescence lifetime data for this chapter was acquired and analysed using Becker 
& Hickl SPCImage data analysis software package. To generate fluorescence lifetime 
images, all fluorescence decays recorded in each pixel were fit with either mono or 
bi-exponential decay models according to Equations (4.4) and (4.5), respectively, 
with the goodness of fit regulated by the reduced chi-squared, 𝜒2, test.  
 𝐼(𝑡) =  𝐼0exp (
−𝑡
𝜏
) (4.4) 
 𝐼(𝑡) =  𝛼1exp (
−𝑡
𝜏1
) + 𝛼2exp (
−𝑡
𝜏2
) (4.5) 
where 𝐼 is the fluorescence intensity, 𝑡 is the time, 𝐼0 is the fluorescence intensity 
immediately after exaction and 𝜏  is the fluorescence lifetime. In Equation (4.5), 
𝛼1, 𝛼2, 𝜏1 and 𝜏2 are the amplitudes and lifetimes of the two exponentially decaying 
components. These fractional contributions and lifetimes of the two fitted decay 
components were plotted as functions of time, and the mean lifetime (𝜏𝑚𝑒𝑎𝑛) was 
calculated according to Equation (4.6). For all fluorescence lifetime images, the 
goodness of fit parameter 𝜒2 values for various pixels between 0.8 – 1.3 indicated as 
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a good fit. For lifetime imaging all images were gathered until a maximum signal in 
the peak channel of 100 counts was recorded. 
 𝜏𝑚𝑒𝑎𝑛 =  
𝛼1𝜏1
2 + 𝛼2𝜏2
2
 𝛼1𝜏1 +  𝛼2𝜏2
 (4.6) 
To obtain a complete model, the instrument response function (IRF) for a FLIM 
system needs to be taken into account, due to the impact that IRF gives rise to the 
decay function. The IRF is the function the FLIM system would record when it 
detects the laser pulse directly, which describes the shape of the excitation pulse and 
the measurement method.  
In order to achieve accurate fitting, it is necessary to deconvolve the measured 
fluorescence decay data from the IRF. Artificial IRFs can be adopted to the fitting, 
however, these would not elucidate any unique aberrations induced by reflections or 
misshaping of laser pulses in the FLIM set-up. In addition, artificial IRFs cannot be 
used to investigate data which may have a shorter lifetime than the provided IRF.  
Real (measured) IRF data was acquired by parking the laser beam at the centre of the 
optical axis and removing the selective filters before the detector. Neutral density 
filters were positioned before the pinhole for reducing the optical density to protect 
the detector from damage. Measurement of IRF was conducted under the same 
conditions as acquisition of FLIM data. All parameters affecting the timing and the 
time scale (ADC Resolution, TAC and CFD) were held constant for both IRF and 
lifetime measurements. The electronic slider for controlling the laser power was also 
maintained as it can have an effect on the shape of the laser pulse. The real IRF data 
must be reasonably free of fluorescence, so the fluorescent sample was replaced with 
a non-fluorescent scattering object, for example, a glass cover slip, and the resultant 
signal was recorded for one second with a maximum signal in the peak channel of 
50000 counts allows the IRF to be considered as practically noise-free. 
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Figure 4.4 IRF recorded using 473 nm laser at a repetition of 20 MHz. The 
first peak corresponds to initial laser pulse recorded from a glass scattering 
sample and the second peak related to optical reflection within the FLIM 
system. 
 
In Figure 4.4, a typical IRF was measured using the 473 nm laser line at a repetition 
rate of 20 MHz with a glass cover slip as a scattering target. It can be seen that a 
secondary pulse exists which is two orders of magnitude lower in intensity than that 
of original laser pulse occurs 11 seconds earlier. The most likely source of this pulse 
originates from reflections within the optical path of the detection system. 
4.3 Results and Discussion 
4.3.1 Effect of  Measured IRF on Fluorescence Decay Fitting 
To determine the impact of the measured IRF, especially the secondary pulse on the 
fluorescence decay curves, rhodamine was used as the fluorescent calibration 
solution of known lifetime. Rhodamine B aqueous solution is known to have a 
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fluorescent lifetime (measured at 20°C) of 1.74 ns. (222) The fluorescence decay of 
the fluorophore can be fitted with a simple single-exponential. 
 
Figure 4.5 Fluorescence decay profiles for Rhodamine B aqueous solution at 
a temperature of 20°C analysed with both an artificial IRF (top) and a real IRF 
(bottom). 
 
In Figure 4.5, it can be seen that the artificially generated IRF provide a defective fit 
to the measured rhodamine B fluorescence lifetime data as indicated by a high 𝜒2 
value of 6.83 with a corresponding lifetime value of 1.98 ns. The lifetime value 
acquired from the data is greater than that of rhodamine B calibration solution. The 
secondary pulse of the IRF contributes to the exaggerated lifetime value. A good 
mono-exponential fit was obtained when analysing the fluorescence data with the 
real IRF, showing a lifetime value of 1.72 ± 0.02 ns with a 𝜒2 of 1.3 ± 0.1. 
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4.3.2 Calibration of  Viscosity Probe 
Prior to using the molecular rotors mapping, the viscosity within the artificial 
membrane, the relationship between the fluorescence lifetime and viscosity for 
BODIPY based viscosity-sensitive fluorophore were determined in a series of 
methanol and glycerol solutions of varying concentrations of glycerol, Figure 4.6. 
Acquisition of data on the calibration of molecular rotors was under kind help by 
Dr. Niall Geoghegan.  
The obtained relationship plot was also used for the purposes of the calibration of 
the molecular rotors and quantitative measurement of viscosity values from 
converted lifetime. The viscosity probe was initially dissolved in the methanol at a 
concentration of 2.5 µM before glycerol was added to adjust the viscosity. 
Concentrations varied from 50 vol% to 90 vol% glycerol where measured at 
temperatures between 10°C and 60°C to produce the calibration graph. Temperature 
was controlled using a peltier heater coupled to a thermocouple controlled by a PID 
board to maintain the temperature to be constant in this calibration experimentation. 
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Figure 4.6 Selected fluorescence decay traces for BODIPY-C10 recorded in 
methanol and glycerol mixtures (50 vol% - 90 vol% glycerol) of different 
viscosity. 
 
As the concentration of glycerol increases, the fluorescence lifetime of the viscosity 
probe varies markedly as a function of viscosity in accordance with the 
aforementioned theory. The fluorescence decay profiles for each solution mixture 
were mono-exponential indicating only one population of the molecular rotor in each 
solution. Furthermore varying the temperature for each solution determined the 
calibration curve in Figure 4.7. 
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Figure 4.7 Fluorescence lifetime of BODIPY-C10 recorded in 
methanol/glycerol mixtures of various compositions, plotted against 
viscosity. The data were taken over temperature range of 283 K – 333 K. 
 
 
Figure 4.8 A plot of Ln fluorescence lifetime vs Ln viscosity for BODIPY-C10 
yields a straight line with a gradient of 0.44 (R2 = 0.99) in accordance with the 
Föster-Hoffmann equation (viscosities range from 10 cP to 1000 cP). 
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The calibration of the molecular rotors was also performed to investigate the 
viscosity alteration by the temperature shown in Figure 4.7. Importantly, it can be 
concluded that the temperature increase does not have any influence on the 
photophysics of BODIPY-C10 or its function as a molecular rotor, apart from the 
alteration of the viscosity of the solution. In Figure 4.8, a linear relationship was 
observed between the Ln lifetime vs Ln viscosity over two decades of viscosity 
values, which shows good agreement with the modified Förster-Hoffmann equation, 
Equation 4.7, within this viscosity range. Two viscosity dependent constants, 𝐶𝑚 and 
𝛾 were derived by fitting a linear function to the Ln-Ln plot of lifetime vs viscosity. 
The obtained values of 𝐶𝑚 = 4.98 and 𝛾 = 0.44, which are consistent with previously 
reported values. (210) The results of BODIPY-C10 calibration corroborate previous 
literatures in which similar compounds were calibrated over the same range of 
viscosity. (210, 219) The generated calibration plot allows us to use molecular rotors 
lifetimes to determine an unknow viscosity. 
 ln(𝜏) =  ln 𝐶𝑚 + 𝛾ln(𝜂) (4.7) 
4.3.3 Lipid Vesicles Generation 
4.3.3.1 Microfluidic Method 
A glass capillary microfluidic device was used to fabricate double emulsion drops 
with ultrathin membranes, (147) as illustrated in Figure 4.9. We used innermost 
smaller capillary to inject aqueous phase of 8 wt% PEG and 2 wt% PVA, into the 
left tapered capillary. The inner surface of the left tapered injection capillary was 
rendered to be hydrophobic, thus preventing wetting of the innermost aqueous phase 
on the capillary wall. We used this tapered capillary to inject the middle oil phase, 
DOPC dissolved in a mixture of chloroform and hexane which volume ratio is 36:64; 
the total lipid concentration is 5 mg/ml. The viscosity probe BODIPY-C10 was 
added into DOPC solution at a concentration of 0.1 mol%.  
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We injected the innermost aqueous phase and middle oil phase at flow rate of 500 
μl/h and 400 μl/h, respectively; under these conditions the innermost aqueous phase 
formed large water in oil emulsion drops within the left tapered capillary, as shown 
in the schematic illustration in Figure 4.9. We then pumped the outer aqueous phase, 
a 10 wt% PVA solution, through the interstices between the left tapered capillary and 
the square capillary, at flow rate of 2000 μl/h. We treated the right tapered capillary 
to modify its surface hydrophilic, thus preventing wetting of the middle oil phase on 
its wall. To prevent osmotic stresses, we collected the highly monodispersed double 
emulsion drops in a 50 mM NaCl solution having the same osmolarity as the inner 
water cores. 
 
Figure 4.9 Schematic of preparation of thin-shell double emulsions in a glass 
capillary microfluidic device; high speed camera snapshot of the formation 
process of double emulsions. Scale bar denotes 200 µm. 
 
Monodispersed water-in-oil-in-water double emulsions were successfully generated 
using this device. The double emulsion droplets were incubated at the room 
temperature in the 50 mM NaCl collection buffer. In the similar fashion of the 
formation of lipid vesicles described in the Chapter 3, chloroform the good solvent 
for the lipids rapidly diffused from the thin shells of double emulsions to the 
surrounding medium. The reduction in the solvent quality induced two lipid 
monolayers, which subsequently came together, forming a lipid bilayer membrane.  
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As a consequence, the stable lipid vesicles were completely transformed from 
microfluidically produced the double-emulsion templates with ultrathin shells. As 
shown in Figure 4.10, owing to the precise control over the size of the double-
emulsion templates, as-formed lipid vesicles are extremely uniform with the mean 
diameter of lipid vesicles is 178.5 ± 6.3 µm, Figure 4.10(A). 
 
Figure 4.10 (A) Optical microscope image of the resultant monodisperse lipid 
vesicles producing using flow rates equal to 500 µl/h, 400 µl/h and 2000 µl/h 
for respectively inner, middle and external phase. Scale bar represents 200 µm; 
(B) Size distribution (diameter) of the measured lipid vesicles (n = 111). 
 
Figure 4.11 shows as-prepared lipid vesicles with their bilayers stained by BODIPY-
C10 molecular rotors. The resultant liposomes were highly monodispersed, in which 
the molecular rotors distributed homogeneously in the lipid vesicles boundaries. 
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Figure 4.11 Confocal laser scanning microscope image of lipid vesicles with 
BODIPY-C10 entrapped in bilayers produced by microfluidics: (A) Confocal 
images of as-formed uniform lipid vesicle observed under a 5x objective lens. 
Scale bar is 200 µm; (B) Inset in (A) is confocal image of lipid vesicles imaged 
by a 20x objective lens. 
 
4.3.3.2 Electroformation Method 
High quality of giant unilamellar vesicles (GUVs) incorporated with BODIPY-C10 
were produced at high yield using electroformation as shown in Figure 4.12. 
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Figure 4.12 Confocal laser scanning microscope image of DOPC GUVs within 
electroformation chamber that were labelled with 0.5 mol% molecular rotors, 
showing the high yield possible using electroformation. Scale bar is 20 µm. 
 
Owing to the mechanism of the electroformation method, the organic solvent used 
to dissolve lipid molecules was degassed for several hours ensuring that the solvent-
free environment resulted in the self-assembly of the lipids into several stacks of 
bilayers on the ITO slides surface. A complete rehydration with an aqueous solution 
was initiated in the presence of an AC electric filed. Growth and detachment of 
GUVs within the electroformation chamber was obtained by gradually reducing the 
AC frequency in a stepwise fashion. As a consequence, the electroformed GUV 
compartments were enclosed by a single lipid bilayer without any organic solvent. 
4.3.4 Viscosity Studies in DOPC Bilayers – GUVs and 
Microfluidic Fabricated Lipid Vesicles 
Lipid vesicles templated from thin-shell double emulsion droplets were produced by 
microfluidics, providing a useful model system to mimic the biomembranes of cells. 
The resultant lipid bilayers were formed as a result of the dewetting process, which 
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was with the assistance of an organic solvent mixture, chloroform and hexane. 
However, the viscosity of artificial biomembranes as well as biocompatibility were 
strongly influenced by the presence of organic solvent. The combination of FLIM 
and the viscosity-sensitive molecular rotors pave the way to monitor the dewetting-
induced artificial bilayer formation, Figure 4.13, through comparing the viscosity 
within microfluidic prepared membranes with the solvent-free membrane 
environment formed via electroformation. 
 
Figure 4.13 Schematic demonstration of fluorescence lifetime measurement 
of dewetting-induced bilayer formation with incorporation of BODIPY-C10 
rotor in the membrane. 
 
The fluorescent lifetime of the molecular rotor BODIPY-C10 was measured in both 
lipid bilayers formed by microfluidics and electroformed lipid bilayer over a course 
of time, at ambient (room) temperature. Lipid vesicles were prepared in both 
methods only composed of DOPC, which is presented for the fluid phase at 20°C. 
In terms of lipid vesicles produced by microfluidics, the fluorescence lifetime 
measurement started from the collection off-chip, and were tested at another two 
time points, 20 minutes and 40 minutes respectively. The electroformed liposomes 
were characterised in the same fashion. FLIM was used to determine the lifetime 
value, and therefore the viscosity of two types of vesicles. 
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Figure 4.14 Representative fluorescence lifetime images of two kinds of lipid 
vesicles imaged with BODIPY-C10 rotor and the corresponded lifetime 
values: (A) FLIM image of a microfluidic produced lipid vesicle (left) and a 
electroformed liposome (right) at 0 minute; (B) Both two types of vesicles 
imaged at 20 minute after preparation; (C) Fluorescence lifetime images of 
two vesicles at 40 minute; (D) The corresponded lifetime histograms of two 
vesicles measured at 0, 20 and 40 minutes. The fluorescence lifetime range 
500 – 3000 ps. Scale bar for microfluidic fabricated and electroformed lipid 
vesicles are 100 µm and 20 µm, respectively. 
 
In Figure 4.14, the lifetime images for BODIPY-C10 in DOPC were best fit to a bi-
exponential decay. This is in contradiction to the reported mono-exponential decays 
in fluid phase bilayer, for example DOPC bilayers, for BODIPY based viscosity-
sensitive rotor. (210, 212, 223) In comparison with fluid phase bilayer fit with a 
mono-exponential decay, the source of the second decay component occurred in 
both vesicle generation methods may originate from the aggregation of BODIPY-
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C10 rotor which may form during the electroformation process and/or the dewetting 
process, respectively. As can be seen from the representative lifetime images in 
Figure 4.14 (A-C), which were plotted in the same colour scale, the lifetimes of 
microfluidic constructed lipid vesicles gradually increased. In contrast, the lifetimes 
of electroformed liposomes measured at three time points with 20-minute interval 
remained constant.  
Further, both trends of lifetime alteration over time for two different vesicles are 
shown in Figure 4.14(D) in which lifetime distributions and the average lifetimes of 
double-emulsion templated lipid vesicles at 0, 20 and 40 minutes were 975 ps, 1375 
ps and 1550 ps are displayed.  This showed a significant, 59% increase in the average 
lifetime value, while the average lifetimes of electroformed liposomes showed little 
change (at around 1950 ps - presenting an unperturbed state of lifetimes over 40 
minutes).  
The increase of lifetimes of microfluidics-artificial bilayer results, perhaps result from 
the dewetting process occurring in the membranes over the period of the 
measurements (as a result of evaporation of volatile solvent (chloroform) and the 
diffusion of hexane into surrounding aqueous phase). As depicted in Figure 4.13, 
during the dewetting process, the tail groups of the lipid molecules gradually stick 
together where fatty acid chains tangle resulting in a more viscosity membrane 
environment compared with organic solvent existed membrane. 
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Figure 4.15 Comparison of lifetimes and viscosities measured in two 
population of vesicles made by microfluidics (red data) and electroformation 
(patterned data). Error bars represent the standard deviation (n = 3 – 4). 
 
As discussed above, based upon the lifetime value obtained from the single vesicle 
during 40 minutes, the lipid vesicles’ bilayers tend to be more viscous, whereas no 
significant alteration can be seen in electroformed vesicles over the range of lifetimes 
measured. In order to further quantitatively explore the membrane viscosity of lipid 
vesicles, 3 – 4 vesicles were imaged and characterised by FLIM for both fabrication 
approaches. In Figure 4.15, the lifetimes measured by FLIM for two types of vesicles 
are shown, demonstrating a good agreement with the trends shown in Figure 
4.14(D). A similar significant rise in calculated viscosity of microfluidic-based 
liposomes are presented in Figure 4.15. At the beginning of FLIM measurement, the 
target membrane was in fact, thin-shell double emulsion membranes where solvent 
mixture homogenously entrapped, resulting in a less viscos membrane (71.96 ± 10.88 
cP). As dewetting-assisted bilayer formation occurred the calculated viscosities of 
semi-formed bilayer at 20 minutes was 149.02 ± 13.06 cP, and 254.63 ± 33.82 cP at 
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40 minutes. The more viscous membrane was, the less organic solvent encapsulated 
in the bilayers. The viscosities of electroformed liposomes for 0, 20 and 40 minutes 
were 369.80 ± 13.57 cP, 372.47 ± 29.35 cP and 387.96 ± 18.75 cP respectively, 
indicating these solvent-free bilayers were good biomembrane references used to be 
compared with vesicles built by the microfluidic technology. 
 
Figure 4.16 CLSM image of the localisation of BODIPY-C10 molecular rotors 
after 60 minutes: (A) Green channel of as-formed lipid vesicles with 
concentrated BODIPY-C10 forming an oil pocket at the top; (B) Bright field 
of lipid vesicles; (C) Merge channel of double emulsion templated lipid 
vesicles. 
 
Imaging of microfluidic-based vesicles was also performed using FLIM at 60 
minutes, however the remaining solvent was less dense than the inner aqueous core, 
and an oil pocket formed at the top of the resultant lipid vesicles. (147) BODIPY-
C10 is an oil soluble fluorophore, and it partitioned upward to the top of vesicles, 
leaving less rotors in the bilayer for the lifetime signal acquisition, Figure 4.16. For 
this reason the values of calculated viscosity at 60 minutes were not able to record.  
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In future, increasing the concentration of the molecular rotor in the membrane, for 
instance to 0.5 mol% as the maximum rotor concentration to prevent dye 
aggregation, (210) may be a reasonable approach to obtain the long-time viscosity 
measurement. Additionally, a surfactant-controlled complete dewetting through 
adjusting interfacial energies by using a triblock copolymer surfactant has been 
demonstrated, and this may enable such measurements to be made. (151) The precise 
control of interfacial energies can facilitate the entire dewetting process shortly after 
the collection of the double emulsion templates forming the oil-free lipid vesicles, 
which would be helpful to accommodate the rotors within the bilayers rather than 
aggregating in the oil pockets at the top of the lipid vesicles. 
4.4 Conclusions 
In this chapter, the BODIPY-based molecular rotors were used to image viscosity in 
artificial lipid bilayers, in order to assess the utility of lipid vesicles to be synthetic cell 
models, which templated from ultrathin shell double emulsions produced by 
microfluidics, and to investigate the effects of dewetting-assisted bilayer formation 
on membrane viscosity. 
The fluorescence lifetimes of the BODIPY-C10 rotors were first determined in 
methanol/glycerol mixtures of known viscosity in order to calibrate the rotors using 
a Förster-Hoffmann plot. In order to investigate whether temperature affected the 
fluorescence lifetimes of the rotors, the fluorescence lifetimes of BODIPY-C10 in 
methanol/glycerol were measured at 283 K – 333 K, which gave similar linear 
relationships between lifetimes and viscosities while conducting at a series of 
temperatures, implying that BODIPY lifetime is not strongly affected by 
temperature. 
By a mean of microfluidic strategy, monodisperse lipid vesicles were produced in a 
high-throughput format. The lipid vesicles were transformed from templates that 
were in the form of double emulsions with ultra-thin shells. With assistance of the 
dewetting, two independent lipid monolayers “zipped” along the entire interface 
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forming a lipid vesicle. In addition, high qualities of GUVs were produced by an 
electroformation approach by which efficiently avoid organic solvent persisted in the 
biomembranes. 
The BODIPY-C10 rotors were then incorporated into microfluidic-based lipid 
vesicles and electroformed GUVs, in order to investigate viscosity within lipid 
bilayers with an increasing time of 20 minutes. By performing the FLIM 
measurements and comparisons between two kinds of bilayers, our hypothesis 
regarding on the shift of lifetimes towards the value of the electroformed GUVs was 
confirmed. A 59% increase of lifetimes can be seen in microfluidic configuration 
after 40 minutes since the vesicles were prepared. This rise in reported lifetimes was 
due to the dewetting process at water-oil and oil-water interfaces which forced the 
membranes to be solvent free.  
We then proceeded to determine membrane viscosity within two configurations of 
vesicles and showed: (i) a significant rise in calculated viscosity within microfluidic-
based vesicles from 71.96 ± 10.88 cP to 254.63 ± 33.82 cP; and (ii) that there was no 
notable change in electroformed vesicles’ bilayers at a range of time points. These 
experiments showed that microfluidic-based lipid vesicles can serve as novel cell-like 
architectures, especially their bilayer environments were featured similar qualities in 
terms of fluidity property as pure bilayers manufactured using a solvent-free method.  
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Chapter 5 Microfluidic Generation of  
Asymmetrical Bilayer Vesicles as Artificial Cells 
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Chapter 5 describes a novel integrated microfluidic approach for fabrication of 
monodispersed giant unilamellar vesicles with asymmetric bilayers as artificial cell 
models. The vesicles are continuously assembled in two distinct steps within a 
microcapillary microfluidic device, giving an “on-demand” defined composition, 
depending upon the flow rates of fluids. In the first step, water-in-oil droplets are 
stabilised with the first phospholipid phase to form the inner leaflet within an 
injection capillary. These dispersed droplets then flow through a second injection 
channel where a continuous reagent replaces the first monolayer solution to produce 
uniform water-in-oil-in-water double emulsions.  
By controlling the continuous aqueous phase flow rate in the device, the diameter of 
the double emulsions can be varied from 350 µm to 187 µm. We have evaluated 
membrane asymmetry by using fluorescence quenching assays. To demonstrate the 
versatility of the approach, we also engineered hybrid asymmetric bilayer vesicles 
with an independent phospholipid inner-leaflet and diblock copolymer monolayers 
at the outer layer. Our strategy demonstrates the high-throughput fabrication of 
asymmetric bilayer vesicles in an integrated synthesis, with potential applications in 
researching the physical properties of membranes and vesicle drug delivery systems. 
The work described in this chapter has been presented at EMBL Microfluidics 
(Heidelberg, Germany, July 2016). 
5.1 Introduction 
5.1.1 Membrane Asymmetry 
In 1972, Mark Bretscher first reported the existence of partial lipid asymmetry in the 
membranes, which experimentally proved phosphatidylcholine (PC) and 
sphingomyelin (SM) are abundant within exterior layer of the lipid bilayer. (224) Five 
years later, Rothman and Lenard developed the concept of lipid asymmetry in plasma 
membranes, and the degree of lipid species differences between the interior and 
exterior leaflets of the membrane was firmly established. (225) Of the 
glycerophospholipids, phosphatidylcholine (PC) tends to locate in the outer-leaflet, 
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and the aminophospholipids phosphatidylserine (PS) and phosphatidylethanolamine 
(PE) are concentrated in the inner-leaflet. The sphingolipids, sphingomyelin (SM) are 
also confined to the outer-monolayer, (226) as shown in the Figure 5.1. In the 
membranes of cells, the compositional asymmetry can have important consequences 
for such features as membrane permeability, (227) transmembrane protein 
orientation and localisation, (228) and membrane shape as well as stability. (229, 230) 
Additionally, this transmembrane lipid asymmetry provides the two leaflets of 
membranes with different biophysical properties and influences numerous cellular 
functions. For instance, membrane-bound enzymes, like protein kinase C and Na+ 
and K+-ATPase are affected by PS which is located in the inner-leaflet and which is 
an essential co-factor to these enzymes functions, (231) whereas the outer-monolayer 
concentrated PS works as a recognition site for phagocytes. (232) In general, the 
transbilayer phospholipid asymmetry provides a significant property that merits 
detailed study. 
 
Figure 5.1 Schematically illustration of transbilayer distribution of 
phospholipids in human red blood cells. (226, 233) 
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5.1.2 Measurement Methods of  Phospholipid Bilayer 
Asymmetry 
Various methods of determining the lipid sidedness across a bilayer exist, determining 
this property by either direct or indirect methods. Commonly used direct methods 
for studying the lipid asymmetry fall into five general categories: chemical labelling, 
(234) modification by phospholipases, (226) immunochemical methods, (235) 
protein-mediated phospholipid translocation (236) and physicochemical techniques, 
for instance, nuclear magnetic resonance (NMR), electron spin resonance (ESR) and 
X-ray analysis. (235, 237) However, all these direct methods are valid only if the 
reagent, for example, enzymes or chemical probes, which face the outer-leaflet reacts 
only with the lipid on the outer-monolayer and not with the inner layer. It is also 
important that the process of measurement does not induce alterations in the original 
asymmetric lipid arrangement of membranes.  
The rates of chemical or biochemical reactions are often of a different order 
compared to the rate of phospholipid translocation, making many of the direct 
methods, described above, unsuitable for dynamic studies of transmembrane 
asymmetry. Indirect methods have therefore been developed to assess transbilayer 
lipid asymmetry. Annexin V binding is a new fluorescent probe that can be used for 
the detection of cells with PS exposed on the cell surface, (142, 238, 239) as annexin 
V binds only to the PS on the outer-leaflet of bilayer membranes.  
However, the most widely used method for readily visualising membranes with two 
different leaflets, and studying the dynamics of lipid movement between the two 
monolayers, is to use a variety of phospholipid analogues (as phospholipid probes). 
These membrane probes include fluorescent analogues of natural lipids, as well as 
lipophilic organic dyes that have little structural resemblance to natural biomolecules. 
Most of the analogues incorporate a reporter group to the head group or to one fatty 
acid chain of the phospholipid. This can then be easily integrated into the outer-
leaflet of the bilayer and then rapidly quenched by the addition of membrane-
impermeant reagents to indicate the asymmetric arrangement of membranes and 
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assess the movement of phospholipids between the inner-leaflet and outer-leaflet. 
(40, 82, 142) 
5.1.3 Construction of  Asymmetrical Bilayer Vesicles 
Vesicles are aqueous lumen enclosed by bilayer membranes composed of either 
phospholipids (liposomes) (240, 241) or block copolymer (polymersomes) (128, 131). 
They have attracted interest as artificial cell chassis for studying cellular membrane 
biology. (168, 242, 243) However, the majority of existing research relies on well-
characterised symmetrical bilayer vesicles rather than vesicles with an asymmetrical 
bilayer, which much better represents natural cells in terms of complexity and reality. 
Thus, membrane researchers are looking for novel and facile ways of producing 
vesicles with asymmetrical bilayers in order to accurately mimic cells as they exist in 
nature. In the last decade, David A. Weitz and co-workers created a phase transfer 
method to fabricate asymmetrical bilayer vesicles, Figure 5.2(A), (81) which leaves 
inverted micelles transfer the second lipid phase via density gradient between inner 
aqueous solution and lipid phase to achieve resultant asymmetrical bilayer vesicles in 
final watery solution. In Figure 5.2(B), Noah Malmstadt and his team synthesised 
asymmetric giant lipid vesicles by means of a combination of phase transfer methods 
and microfluidic techniques. This method introduced the concept of using 
microfluidics, already a well-developed technology in analytical sciences, as a method 
for preparing vesicles, (39, 162, 244, 245) for complex artificial cell research. (142)  
The production yield of vesicles built using these methods remained low, and the 
methods originally used made the control of the size of the resultant vesicles difficult. 
In Brian M. Paegel’s lab, a new approach based on layer-by-layer assembly within 
microfluidic device, as depicted in Figure 5.2(C) was detailed. (82) Uniform-sized 
asymmetric vesicles were produced in the microfluidic device, but the collection of 
the vesicles for off-chip experimentation was unreliable due to fragile nature of 
phospholipid membrane.  
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Recently, Paul R. Chiarot’s lab, Figure 5.2(D), and Ocsar Ces’s group, Figure 5.2(E), 
reported new approaches on microfluidic fabrication of vesicles that have 
asymmetric bilayers. (40, 246). The devices used for building up vesicles were, 
however, difficult to design and operate in practical experiments. In addition to the 
complexity of the devices, the materials the devices were constructed from, 
polydimethylsiloxane, PDMS, is a delicate elastomer that reacts with organic 
solvents, such as toluene and chloroform, which are essential reagents for dissolving 
both phospholipids and block copolymers. Exposure to these reagents results in 
swelling of the PDMS device, collapsing channels within it, and degrading the 
performance of vesicles formation. (247) 
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Figure 5.2 Methods of producing vesicles with asymmetric bilayers: (A) 
Schematics of phase-transfer technique uses to engineer asymmetric bilayer 
vesicles; (81) (B) Single droplets are formed in microfluidic chip, and then by 
using phase-transfer method to form the second distinct lipid outer-leaflet; 
(142) (C) Layer-by-layer approach showing the generation of asymmetric 
liposome through trapping single droplets, and then flowing different lipid oil 
phases assembling the asymmetric bilayers; (82) (D) Schematic illustration of 
total synthesis of asymmetric vesicles by using a similar layer-by-layer method 
within a PDMS microfluidic device; (40) (E) 2D schematics of the 
microfluidic set-up for constructing asymmetric vesicles. (246) 
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5.2 Materials and Methods 
5.2.1 Materials 
Experiments were conducted with the following phospholipids: 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) (Sigma), 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(biotinyl) (Biotinyl-PE) and cholesterol (Avanti Polar 
Lipids, Inc.). Diblock copolymer, poly(butadiene-b-ethyleneoxide) (PB-b-PEO) was 
acquired from Polymer Source (Canada). As tracer lipids, we used (n-(Texas Red 
sulfonyl)-1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine,triethylammoniumsalt) (TR-PE), 2-(12-(7-nitrobenz-2-oxa-
1,3-diazol-4-yl)amino)dodecanoyl-1-hexadecanoyl-sn-glycero-3-phosphocholine 
(NBD-PC) (Life Technologies), (n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-
dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt) (NBD-
PE) (Avanti Polar Lipids, Inc.). Streptavidin used for modifying the surface property 
was purchased from Sigma. Phosphate-buffered saline (PBS) (Sigma) buffer was 
utilised to prepare streptavidin solution. 
To dissolve phospholipids and diblock copolymer, a solvent mixture of chloroform 
and hexane (Sigma) was prepared. For the watery phases, we dissolved poly(ethylene 
glycol) (PEG, Mw = 6000 Da, Sigma) and poly(vinyl alcohol) (PVA, Mw = 13,000-
23,000 Da, Sigma) in deionised (DI) water to 10 wt% as inner aqueous solution; 10 
wt% PVA solution was produced as the continuous aqueous phase. A 50 mM NaCl 
(Sigma) solution was used to collect double emulsion drops. Osmolarities of all 
aqueous phases were measured using an osmometer (3300 Micro-Osmometer, 
Advanced Instruments, Inc., UK). For fluorescence quenching assay, sodium 
dithionite (Sigma) was dissolved in 50 mM NaCl solutions. 
5.2.2 Preparation of  Solutions 
The inner-leaflet and outer-leaflet lipid solutions (DOPE or DOPC 70 mol% and 
cholesterol 30 mol%) were solubilised in an organic solvent mixture (chloroform 36 
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vol% and hexane 64 vol%) to a total lipid concentration of 5 mg/ml. All fluorescent 
lipid probes were additionally added to each lipid phase at 0.5 mol% for fluorescence 
imaging and fluorescence quenching assay. In fluorescence quenching assay, 15 wt% 
of Biotinyl-PE was also added to the outer-leaflet solution for both configurations. 
A polymeric outer monolayer of hybrid bilayer was prepared by dissolving PB-b-
PEO in the solvent mixture to make it 5 mg/ml. To form the inner watery solution, 
PEG and PVA were dissolved to 10 wt%. 10 wt% of PVA solution was used as the 
outer aqueous phase to ultimately form double emulsions. The collection phase was 
50 mM NaCl. Sodium dithionite was dissolved in the collection solution at 0.1 M as 
the quenching reagent. All aqueous solutions were filtered through 0.25 µm syringe 
filter (Life Technologies). 
5.2.3 Fabrication of  Microfluidic Device 
The microfluidic device was assembled by microcapillaries. The microfluidic device 
platform was made of two glass slides. Glass slides were glued together for 5 minutes 
using epoxy (Devcon) as in Figure 5.3(A, B). The device consists of four circular 
glass capillaries. The innermost injection round capillary with 580 µm inner diameter, 
1 mm outer diameter (WPI), was tapered by a gas torch and the tip was adjusted by 
sand paper to 40-60 µm inner diameter. This innermost capillary was inserted into 
the untapered opening of the middle injection circular glass capillary, whose inner 
and outer dimensions are 200 µm and 1 mm (WPI), to create a biphasic flow within 
the middle injection capillary and forming a stable water jet as shown in Figure 5.3(C, 
E, F)  
The outermost injection cylindrical glass capillary, with inner diameter 1.17 mm 
(Harvard Apparatus), was pulled by a micropipette puller (P-97, Sutter Instrument, 
Inc.) and sanded to shape the tip into 100 µm. To make the inner wall hydrophobic, 
the glass capillary was treated with Sigmacote (Sigma) for 30 minutes and then 
washed with isopropyl alcohol. Next, a round collection capillary of the same 
dimension as the outermost injection capillary and with a 200 µm tapered tip was 
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dipped into 2-[Methoxy(polyethyleneoxy)propyl]-trichlorosilane (Fluorochem Ltd.) 
to render the glass capillary surface hydrophilic. It was then rinsed with DI water.  
After dripping and rinsing the capillaries, the remaining fluids were then removed 
with compressed air prior to assembly. To complete the fabrication of the suite of 
injection capillaries, the middle injection tube was inserted into the unprocessed end 
of the last injection capillary. The tips of the outermost injection capillary and the 
collection tube were coaxially aligned inside a square glass capillary (VitroCom) under 
an optical microscope at 10x magnification. These were then glued to the platform 
as in Figure 5.3(D). Lastly, dispensing needles, used as inlets of fluids, were connected 
at either the junctions between capillaries or their ends by using 5 minutes epoxy as 
illustrated in Figure 5.3(G). Figure 5.3(H), shows a digital image of the fabricated 
microfluidic device used for manufacturing vesicles with transbilayer asymmetry. 
 
Figure 5.3 Step-by-step instructions on building a microfluidic device for the 
fabrication of asymmetric bilayer vesicles: (A, B) A square capillary was glued 
to the device platform made of two glass slides; (C) Four tapered cylindrical 
capillaries were polished to modify the diameter of the orifices; (D) The two 
glass capillaries with the largest outer dimeters were opposingly inserted 
inside the square capillary and glued to the device platform; (E) The middle 
injection glass capillary was inserted into the opening end of the lager 
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injection tube; (F) The last injection capillary was positioned such that the tip 
was slightly inserted into the middle injection glass tube and glued to the 
glass slide; (G) Syringe needles were cut and glued onto the device and serve 
as the inlets of the microfluidic device; (H) Digital image of a fabricated 
microfluidic device for the preparation of vesicles with asymmetric 
agreements within the membrane. 
 
5.2.4 Operation of  Microfluidic Device 
The inner and outer aqueous phases were loaded into 10 ml and 20 ml plastic syringes 
(BD) respectively and lipid or polymer phases into 5 ml glass syringes (SGE). All 
reagents were injected into the microfluidic device using syringe pumps (Harvard 
Apparatus) through silicone tubing with inner and outer diameters of 1 mm and 3 
mm respectively (VWR). The tubing was used in all connections between syringes 
and dispensing needles on the device. The flow rates of the innermost aqueous phase, 
lipid 1, lipid 2/polymer and the continuous aqueous phase were typically tuned to be 
2500, 400, 600 and 3000 µl/h, respectively. The formation process of emulsion 
droplets was monitored by using a Zeiss Axio Imager. A2 microscope (Carl Zeiss 
MicroImaging) equipped with a Phantom V1611 high-speed camera (Vision 
Research Inc.). Once produced, double emulsion drops were collected into a vial 
called the collection bath, that contained a 50 mM NaCl solution. 
5.2.5 Surface Treatments 
For fluorescence quenching assays of the asymmetry of microfluidically-synthesised 
membrane, it was imperative that the vesicles remained stationary at the bottom of 
the observation chamber (µ-Slide 4 Well, Ibidi) for the duration of the measurements. 
This was achieved through a well-established coupling method of biotin-streptavidin 
interaction displayed in Figure 5.4, as it has been demonstrated to maintain 
immobilisation of vesicles on the surface of support substrates. (248, 249) 
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Figure 5.4 Schematic describing the biotin-streptavidin binding utilised in 
fluorescence quenching assay. Asymmetric bilayer vesicles with biotin 
conjugated lipids on the outer-leaflet anchor to the streptavidin-coated 
surfaces. 
 
The observation chambers were sonicated in DI water for 30 minutes followed by 
drying under N2, then plasma treatment was applied to the chambers rendering 
surfaces hydrophilic. Streptavidin was dissolved in PBS buffer at 1 mg/ml first, and 
thereafter diluted to be 0.1 mg/ml for surface modification. 0.1 mg/ml streptavidin 
solution was added into each well of observation chambers followed by incubation 
at 4oC for 2 hours resulting in physical adsorption of streptavidin on the surfaces. 
Prior to conducting assay with the chambers, they were gently flushed 3 times with 
50 mM NaCl solution. 
5.2.6 Fluorescence Quenching Assay Experiment 
To validate the asymmetry of the lipid vesicle membranes, fluorescence quenching 
assay was applied. Lipid vesicles with NBD fluorophore in either inner-leaflet or 
outer-leaflet were measured as soon as the vesicles were transformed from double-
emulsion templates. Firstly, a 200 µl suspension of vesicles with only the outer 
monolayer labelled with NBD-PC was added to an observation chamber where 
fluorescence images were taken. 50 µl of the fluorescent quencher sodium dithionite 
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was added into the chamber as a 1 M solution dissolved in DI water. The 
fluorescence emission of the asymmetric lipid bilayer vesicles was measured before 
and after addition of quencher solution. 
Vesicles that were stained with NBD-PE on the inner-leaflet were measurement 
conducted in the same fashion. Multiple images of each vesicle were taken 
throughout the fluorescence quenching assay using the time-series function of the 
confocal laser scanning microscopy (Zeiss LSM 5 Live). Quantitative fluorescence 
comparisons were made by normalising the average fluorescence intensities of each 
type of vesicles (n = 3) over the entire quenching assay experiment. 
5.3 Results and Discussion 
5.3.1 Asymmetric Bilayer Vesicles Assembly 
Asymmetric bilayer vesicles were fabricated utilising a two-step emulsification 
process with two types of phospholipids within a single microfluidic device. The 
strategy is schematically demonstrated in Figure 5.5(A). First of all, a stable aqueous 
coaxial jet at the centre of the capillary surrounded by a lipid phase, which was 
flowing along the inner surface of innermost injection capillary due to the 
hydrophobic nature of the capillary wall, (60) was formed in the middle injection 
capillary through injecting the inner aqueous phase into the lipid 1 phase. The 
formation of the stable water phase jet rather than plug-like water-in-oil droplets is a 
result of the degree of increasing interfacial confinement due to the decreasing inner 
diameter of the injection tube, Figure 5.5(B). This water jet was well coated with lipid 
1 phase to form the inner-leaflet of bilayer, which implies that there was no excess 
lipid 1 phase flowing into the next injection capillary that could then emulsify at the 
orifice of the middle tube, resulting in the production of a train of separate water-
lipid 1-lipid 2 and lipid 2 drops in the last injection capillary as exemplified in Figure 
5.5(A). The middle injection capillary was designed to avoid interfere between the 
two lipid phases and to ensure that each leaflet is assembled independently. Next, in 
the outer injection glass capillary, only lipid 2 solution was delivered in order to 
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assemble the outer-leaflet of the asymmetric bilayer. These drops flowed along the 
outer injection capillary and re-emulsified at the tip in the discontinuous dripping 
regime, resulting in monodisperse double emulsions with two distinct phospholipid 
phases on each interface in the bilayer. As Figure 5.5(C) shows, which was acquired 
by high-speed camera, uniform spherical double emulsions were ultimately collected 
in the glass collection capillary. Subsequently, the double emulsions were collected in 
a glass vial containing 50 mM NaCl. 
 
Figure 5.5 Microfluidic fabrication of water-lipid 1-lipid 2-water double 
emulsions: Here (A) Schematic of a glass capillary microfluidic device for 
fabrication of asymmetric bilayer vesicles; (B) Optical microscope image 
showing the emulsified water-lipid 1 jet by the continuous lipid 2 phase within 
the outer injection capillary; (C) High-speed optical microscope image of 
continuously produced water-lipid 1-lipid 2-water double emulsions with 
ultrathin shells. Scale bars denote 200 µm. 
 
The highly monodisperse double emulsions were used as templates to form the 
eventual lipid vesicles with asymmetric bilayer by removing the organic solvent from 
the intermediate layer of the double emulsion, which is known as the dewetting 
method and depicted in Figure 5.6(A-D). (39, 243, 250) Chloroform is a good solvent 
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for phospholipid dissolution and more soluble in aqueous phase than hexane fraction 
of organic solvent mixture, (251) enabling chloroform fraction started to evaporate 
and diffuse into external environmental aqueous phase rapidly right after collection, 
therefore leaving the shell of double emulsion to be hexane concentrated, which is a 
bad solvent. The depletion in quality of solvent induced attractive interaction 
between internal and external lipid leaflets forcing them into a closer contact, and as 
a result, the hexane fraction was excreted out of the membrane, and two lipid 
monolayers zipped together along the interfaces forming an unilamellar asymmetric 
lipid bilayer membrane.  
As shown in Figure 5.6(A, B) double emulsion droplets were contained in a glass vial 
with collection solution immediately after formation in the microfluidic device. The 
membranes of double-emulsion templates possessed solvent mixture, resulting in the 
translucency of the vesicle membranes. After 2 hours, vesicle membranes became 
transparent due to the solvent (chloroform) evaporating and hexane dewetting, so 
leading to the transformation from double emulsions to vesicles with compact 
asymmetric bilayer formed. 
 
Figure 5.6 Transformation of double emulsion drops to asymmetric lipid 
bilayer vesicles induced by dewetting process: (A) Digital image of double 
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emulsion templates collected right after generation by microfluidic device; 
(B) Digital image of asymmetric lipid bilayer vesicles contained in the glass 
vial. Schematic illustrations of a double emulsion drop with organic solvent 
remaining in the membrane (C); a well-formed lipid vesicle with asymmetric 
bilayer after the action of dewetting (D). 
 
Figure 5.7(A) exhibits a bright field optical microscope image of monodisperse 
double emulsion droplet templates a few minutes after generation, representing 
asymmetric bilayer lipid vesicles on the bottom of the collecting vial. The asymmetric 
membrane lipid vesicles are uniform. Figure 5.7(B) shows that the mean diameter of 
lipid vesicles is 336 µm and its coefficient of variation is 2.73%, demonstrating the 
high monodispersity of the as-formed double-emulsion droplet templates (n = 120 
vesicles were measured). 
 
Figure 5.7 Monodisperse double emulsions collected into a vial: (A) Optical 
micrograph of uniform-sized double emulsions that are the templates of 
asymmetrical lipid bilayer vesicles produced using flow rates at 2500 µl/h, 400 
µl/h, 600 µl/h and 3000 µl/h for respectively inner, lipid 1 phase, lipid 2 phase 
and external phase; (B) Size distribution of double emulsion droplets. Scar 
bars are 500 µm. 
 
The composite asymmetric bilayer vesicles with phospholipid on the inner-leaflet 
and diblock copolymer on the external leaflet were produced in the same fashion, 
but with the lipid 2 phase replaced by diblock copolymer solution delivered in the 
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outer injection capillary. At the middle injection tube, the lipid phase covered the 
aqueous phase quickly, forming the aforementioned water-DOPE jet. Afterwards, 
the stable jet was coated with diblock copolymer solution in outer injection capillary, 
and re-emulsified to be pinched off at the orifice. The diblock copolymer floated 
freely in the double emulsion membranes, and arranged itself at the outer interface 
to form the outer robust polymeric layer. With dewetting, a transition process taking 
place, (243) which ultimately induced the attraction of the inner lipid leaflet and outer 
block copolymer leaflet forming the final composite asymmetric bilayer of the 
vesicles. 
5.3.2 Diameter of  Asymmetric Bilayer Lipid Vesicles 
Generation of double emulsions in the dripping regime at the injection tube orifice 
within co-flowing glass-based microfluidic devices was subject to capillary force, 
which holds the drops in the capillary, and a drag force that draws drops to be 
pinched off. (252) Drop growth and separation is governed by the two 
aforementioned forces. As the drag force, which is proportional to the velocity of 
the exerted flow, exceeds the interfacial tension, (63) it was possible to control the 
size of the drops by varying the velocity of the continuous aqueous phase. The inner 
watery phase and two lipid phases were maintained as constant while adjusting the 
velocity of outer flowing phase (Qo) as 2, 4, 6, 10 and 20 ml/h, respectively. The 
diameters of the double-emulsion templates decreased by raising the outer flow rate 
because of higher drag force employed. Accordingly, the diameters of the resultant 
asymmetric bilayer lipid vesicles monotonically reduced from 350 ± 11.1 µm to 187 
± 10.6 µm (as a power law Equation (5.1)) with increased flow rate of continuous 
phase, as plotted in Figure 5.8. While the velocity of the continuous aqueous phase 
varied, the inner phase and all lipid phases were held at constant flow rates. Images 
inserted in Figure 5.8 show that all the resulting lipid vesicles produced by the 
corresponding outer flow rates remained highly uniform in size. 
 𝐷 =  451.63 (𝑄𝑜)
−0.276 (5.1) 
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Figure 5.8 Size of the asymmetric bilayer lipid vesicles as a function of flow 
rate of continuous phase. The data was fitted with a power function (R2 = 
0.96). (Inset) optical microscope images of monodisperse lipid vesicles 
prepared at the values of outer flow rates (2 ml/h, 4 ml/h, 6 ml/h, 10 ml/h 
and 20 ml/h). Scale bars are 200 µm. 
 
5.3.3 Characterisation of  Lipid Membrane Asymmetry 
We firstly evaluated the asymmetry of lipid vesicle bilayer by confocal laser scanning 
microscopy (LSM 5 Live, Zeiss). Two fluorescent lipids were used as probes to 
distinguish the inner-leaflet from outer-leaflet. The inner layer made of DOPE was 
stained with TR-PE, which is shown in Figure 5.9(C), and the outer DOPC leaflet 
that was labelled with NBD-PC is exhibited in Figure 5.9(D). The merged dual-
channel confocal microscopy image of the synthetic asymmetrical bilayer lipid vesicle 
was exemplified in Figure 5.9(E). The fluorescence intensity profile, Figure 5.9(F) 
taken along the dotted line validated two tracer lipids localised on inner and outer-
leaflet respectively, which confirmed the potential for asymmetry. 
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Figure 5.9 CLSM images of a produced asymmetric bilayer lipid vesicle: (A) 
Schematics of an asymmetric bilayer lipid vesicle; (B) As formed vesicle in 
bright field; (C) Fluorescence of TR-PE labelled of inner-leaflet; (D) 
Fluorescence of NBD-PC labelled of outer-leaflet; (E) Merged channel of TR-
PE and NBD-PC; (F) Profile of fluorescence intensity of the dotted white line 
crossing the asymmetric bilayer lipid vesicle in (E). NBD fluorophore signal 
represented in green and Texas red displayed in red. All scale bars denote 100 
µm. 
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Asymmetrical lipid bilayers were also verified by a fluorescence quenching assay, used 
to investigate the distribution of tracer lipid between the inner and outer monolayer 
of the bilayer. (253) NBD-PE and NBD-PC were used as probes in the inner-leaflet 
and outer-leaflet, respectively. Sodium dithionite was applied as the fluorescence 
quenching reagent to reduce the fluorescence of the NBD-lipid. As the quencher 
molecule cannot diffuse across the lipid bilayer, only the tracer lipid labelled at the 
outer monolayer of bilayer of the vesicle can react with the quencher molecule. (253) 
The fluorescence quenching assay was performed directly after vesicle generation. 
Two types of asymmetric lipid bilayer vesicles were adopted for this assay. Firstly, we 
only labelled the NBD-lipid probe with the inner-leaflet, and left outer-leaflet with 
no fluorophore. The fluorescence emission of this type asymmetric bilayer vesicle 
was measured before and after addition of quencher solution, as shown in Figure 
5.10(A, B). Secondly, we conducted the assay again using vesicles with outer 
monolayers tagged with NBD-lipid probe, and measured the fluorescence signal 
before and after incorporation of quencher molecules in the suspension of vesicles, 
as illustrated in Figure 5.10(C, D). A high degree of asymmetry of the lipid bilayer 
was synthesised by our device. Figure 5.11 shows the kinetics of the quenching, 
which is dominated by the diffusion of the quencher in the outer phase. The reaction 
between asymmetrical lipid bilayer vesicles with sodium dithionite solution can be 
seen in the normalised fluorescence intensity as a function of time. In the scenario 
of inner-leaflet incorporating with NBD-lipid, the fluorescence intensity dropped by 
4%, which demonstrated that 96% of NBD-lipid remained within the inner 
monolayer of the lipid bilayer upon the addition of quencher solution after 240 
seconds. In contrast, when NBD-lipid was added to the outer-leaflet, 96% of total 
fluorescence intensity was rapidly quenched on addition of the quencher. The time 
constant, 𝜏 = 51.9 ± 1.83 s, of the exponential decay was slower than reported, (81) 
due to the use of a highly viscos outer phase (10 wt% PVA). These results confirmed 
that a high degree of asymmetry of the lipid bilayer was successfully and readily 
achieved using our technique. 
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Figure 5.10 Fluorescence quenching assay to demonstrate bilayer asymmetry: 
(A) Schematic of quenching assay test on asymmetric bilayer vesicles with 
only inner-leaflets tagged with NBD fluorophore; (B) An image series (0, 130, 
240s respectively) of inner monolayer labelled vesicles display fluorescence 
signal maintains with reacting to the quencher; (C) Schematic of quenching 
assay test on asymmetric bilayer vesicles with only outer-leaflets tagged with 
NBD fluorophore; (D) An image series (0, 130, 240s respectively) of outer-
leaflet labelled vesicles show reduction of fluoresce signal when exposed to 
the quencher solution. 
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Figure 5.11 Treating asymmetric bilayer lipid vesicles assembled with NBD 
fluorophore in either the inner-leaflets (squares) or the outer-leaflets (circles) 
with quenching agent (inverted triangle) (n = 3). Solid red line represents an 
exponential decay with R2 = 0.99; R indicates the correlation coefficient. Scale 
bar is 100 µm and applies to all images. 
 
5.3.4 Increased Robustness with Block Copolymers 
In the context of real-life applications, lipid bilayers have often been very fragile, 
especially mechanically. (128) To increase the robustness of the vesicles, we have 
developed a new structure where one of the leaflets is made out of a block copolymer. 
Using our microfluidic system uniquely enables us to control the specific contents of 
each individual leaflet. Block copolymers can be constructed to be amphiphiles in 
which one block of molecules is hydrophilic and the other is hydrophobic. Block 
copolymer can aggregate in aqueous medium producing vesicular structure in the 
same fashion as phospholipids, but the polymeric bilayers have better mechanical 
properties due to the large chains available. (128, 131) Contrary to the control 
provided by our method, previous strategies to reinforce vesicles using block 
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polymers resulted in mixtures of lipids/polymers across leaflets, such that both 
leaflets contained some polymer and some lipids. (254, 255) We created asymmetric 
composite vesicles by replacing one of the lipids with PB-b-PEO. The membranes 
can then be formed when the diblock copolymer arranges at the outer interface. After 
dewetting, this ultimately led to the aggregation of an inner lipid leaflet and an outer 
block copolymer leaflet, forming the final composite bilayer, Figure 5.12(A). 
Similarly to the lipid-lipid bilayers, we characterised the asymmetry of the lipid-
polymer bilayer by confocal laser scanning microscopy (LSM 5 Live, Zeiss), Figure 
5.12(B-D). Figure 5.12(C) shows a calcein dye (green fluorescence) encapsulated 
within the vesicle, surrounded by the DOPE inner-leaflet that was stained by 0.5 
mol% of TR-PE, Figure 5.12(D). This analysis confirmed the presence of a full lipid 
leaflet, that will be supported by a copolymer outer leaflet. 
The composite bilayer structures offer the capability to control the functionality of 
each leaflet independently. For example, an inner lipid leaflet carries biocompatibility 
that would benefit encapsulation of biologically-active components, while the outer 
polymeric leaflet allows a stronger structure. It could also advantageously enable to 
orient membrane spanning elements (proteins and channels) based on specific 
affinity. 
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Figure 5.12 A produced hybrid bilayer vesicles: (A) Schematic illustration of 
hybrid bilayer vesicles with lipid-coated inner-leaflet and diblock copolymer-
coated outer-leaflet; (B) Bright filed optical microscope image of a synthetic 
hybrid bilayer vesicle; (C) CLSM image of copolymer reinforced vesicle with 
encapsulation of calcein dye in the aqueous phase; (D) CLSM image of lipid-
coated inner-leaflet of a hybrid bilayer vesicle. Scale bar is 100 µm. 
 
5.4 Conclusion 
A novel capillary microfluidic device presented in this Chapter provides not only a 
facile, but also robust approach to continuously produce monodisperse asymmetric 
bilayer vesicles with tailored bilayer composition at high-throughput. By adjusting 
the flow rate of the continuous fluid in the microfluidic device, the diameter of 
asymmetric bilayer vesicles was simply controlled, ranging from 187 µm to 350 µm. 
As-formed asymmetric bilayer lipid vesicles were examined by fluorescence 
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microscopy and fluorescence quenching assay to confirm the asymmetric 
arrangement within the bilayer. Asymmetric lipid bilayers showed as high as 96% 
degree of asymmetry when treated with quenching agent during the assay. 
Furthermore, we engineered a new type of bilayer, in which phospholipid (DOPE) 
formed the inner-leaflet and diblock copolymer (PB-b-PEO) coated to form the 
external leaflet. To the best of this author’s knowledge this is the first time polymer 
reinforced bilayer vesicles have been synthesised in a microfluidic device. The 
asymmetric bilayer vesicles produced by our strategy hold the potential to be used as 
artificial cell chassis to explore membrane biology and as cargo carriers for drugs. 
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Chapter 6 Conclusions and Future 
Perspectives 
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In living systems the basic building unit, cells, are the highly advanced microreactors 
in which all complicated biochemical reactions occur, driving the processes of life 
from birth to death. Their complexity has inspired not only biologists, but also 
engineers and physicists to think about building a living cell from scratch. This task 
has attracted attentions of scientists from all over the world, amongst whom from 
Europe have recently created an initiative aiming to meld the efforts together and 
speed progress toward the ambition: Engineering of Synthetic Life. (256) 
Accomplishing this goal of constructing a cell from the bottom up would not only 
provide insight into the fundamental process in natural cells but also pave the way 
for real-world application, for example better drug tests, patient-tailored medicine. 
Prior to synthesis of a synthetic cell that displays biological functionality as a mimic 
of certain aspects of living cells, building the boundaries of cell-like mimics is the 
most important step. This membrane is a semipermeable barrier not only delineates 
the interior from exterior, but also permits small molecules to pass into the cellular 
space. Furthermore,  the membrane plays a crucial role in evolution as it separates 
(257) different genomes from one another reducing the problem of inactive parasites. 
In this thesis, the overarching goal was to develop and fabricate droplet-based 
microfluidic devices in which artificial membranes were synthesised. In other words, 
the overall findings obtained during the research underpin the bottom-up 
construction of vesicle-based synthetic cell compartments and related membrane 
properties for the investigation of incorporating with membrane proteins. In the 
preceding chapters we reached several key breakthroughs towards achieving this 
goal. 
6.1 Summary of  Findings 
Chapter 3 aimed to offer new routes to the construction of cell-like compartments 
using droplet-based microfluidic technique. These vesicular structures were 
transformed into artificial cells by performing in vitro transcription and translation. 
Further, highly functional artificial cell chassis were produced based on these artificial 
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cell constructs with certain types of membrane proteins incorporated into the 
bilayers. 
Chapter 4 is concerned with introducing FLIM instrument into the characterisation 
of boundary systems of artificial cell mimics with the assistance of the molecular 
rotors. By taking advantage of microfluidic technique, the molecular rotors dissolved 
with phospholipid molecules in the volatile oil phase formed bilayers of double 
emulsion droplets. The combination of FLIM with molecular rotors shed light on 
the measurement of dewetting-induced viscosity change within artificial cell 
membranes through detecting the alteration of the lifetime of viscosity-sensitive 
molecules during the time course. In addition, we proposed this method was capable 
of tracking the amount of oil trapped in the bilayer gives the evidence of 
microfluidically fabricated vesicle-based synthetic cells are excellent models for the 
investigation of cell features. 
In Chapter 5 we demonstrated a new capillary-based microfluidic strategy so as to 
producing vesicles featured with asymmetric arrangement in their bilayers. Initial 
attempts with the devised microfluidic device was to generate asymmetric bilayer 
lipid vesicles which are able to be used as more accurate cell-mimicry models in terms 
of lipid bilayer composition between two independent lipid monolayers. By 
characterising the asymmetric bilayers using confocal laser scanning microscopy and 
the fluorescence quenching assay, it can be seen that bilayers equipped with high 
degree of asymmetry was readily acquired using our device. Importantly, an advanced 
geometry of bilayer was constructed within the microfluidic device, is hybrid 
asymmetric bilayer namely as lipid stabilised the inner-leaflet and outer-leaflet was 
coated with block copolymer molecules. 
6.2 Future Work and Outlook 
The experimentation works presented in this thesis have opened up several avenues 
which could be explored in future. The directions of the potential studies fall into 
two parts. The first is exploring the potential application in building a cell from the 
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bottom up. The second involves developing a better understanding of the artificial 
cell modes developed in this thesis. 
6.2.1 Microfluidics-Assisted Division of  Cell Models 
Several key advancements of engineering of cell model chassis using microfluidics 
for high-level functionalities have been accomplished in this thesis. As the models 
for mimicking cells, reproduction through cell division is a key signature of protocells. 
Apart from bringing biological machinery to constrict and divide the cell-mimic 
models, it is also intriguing to explore this process by applying physical forces. 
Recently Zhao et al. has demonstrated a passive three-dimensional splitting method 
based on capillary systems. Droplets flowed into a θ-shaped glass capillary with 
identical subchannels, resulting in a symmetric division of droplets. (258) Thus, a 
microfluidics-assisted approach which is the integration of a capillary-based lipid 
vesicles generator and the splitting device, could accomplish this task, as shown in 
Figure 6.1. 
 
Figure 6.1 Scheme of the splitting process. Lipid vesicles generate at first 
stage and then flow into a compression capillary for aligning lipid vesicles 
with the split capillary. 
 
Double emulsion droplets templates can be produced using the same protocol 
described in Chapter 3. The re-injection of as-formed lipid vesicles can be performed 
by connecting the outlet of the double emulsion generator and inlet of the splitting 
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device using a tubing. By carefully selecting the dimension of the compression 
capillary in which lipid vesicles will be well aligned in the centre of the capillary for 
the next step splitting process. A θ-shaped capillary will be employed as a splitter in 
this device providing passive force for droplets division process. 
6.2.2 Microfluidic Assembly of  Complex Vesicle Networks as 
Artificial Cells 
Multicompartmentalisation is a significant feature of cells, allowing separation and 
protection of biological compounds within the membrane walls. These systems have 
recently been developed for use as cell mimicry. (259, 260) In each confined 
compartment, different independent enzymatic reactions take place simultaneously, 
imitating accurately (high spatiotemporal control) the biochemical reactions occur in 
eukaryotic cells. (261) By designing and preparation of these complex systems, we 
can have simplified biomimetic models serve as a tool for better understanding of 
complex cellular mechanism. A hierarchical capillary microfluidic device could tackle 
the issue of fabrication of highly monodisperse well-defined multicompartment 
systems, Figure 6.2. Briefly, the entrapped single vesicle is formed by microfluidically 
prepared double emulsion templated and then are reinjected into microfluidic device 
as the inner phase to construct lager vesicle-loaded double emulsion droplets. 
Further, the capillary microfluidic device offers considerable flexibility in 
encapsulation of distinct droplets in the host droplets, (262) which enables the 
creation of complex inner vesicle networks in the matrix cell model. 
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Figure 6.2 Schematics illustration of multistep microfluidic devices for the 
hierarchical assembly of complex vesicle networks (multicompartment 
systems) as new structured artificial cell models. Image modified from (263). 
 
6.2.3 Highly Oriented Transmembrane Proteins Induced by 
Asymmetric Lipid Bilayer  
In natural cell membranes, the transmembrane proteins have a well-defined 
orientation leads to specific biological function. (264, 265) However, the integral 
membrane proteins are randomly inserted without a preferred direction losing the 
information about the orientation as long as they are incorporated into the artificial 
symmetric model membranes. In Chapter 5, we also demonstrated a microfluidic 
route to the production of monodisperse asymmetric lipid vesicles with tailored 
bilayer composition at high-throughput. This asymmetric character of lipid bilayers 
plays a crucial role for many membrane-related processes like insertion and 
orientation of transmembrane proteins. (266) 
In conclusion, our new microfluidic techniques can produce bilayers with high 
degree of asymmetry would offer particularly interesting approach to control over 
the orientation of integral membrane proteins in the membranes. 
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